[go: up one dir, main page]

CN112745428B - A kind of preparation method of olefin-olefin alcohol copolymer - Google Patents

A kind of preparation method of olefin-olefin alcohol copolymer Download PDF

Info

Publication number
CN112745428B
CN112745428B CN201911049604.4A CN201911049604A CN112745428B CN 112745428 B CN112745428 B CN 112745428B CN 201911049604 A CN201911049604 A CN 201911049604A CN 112745428 B CN112745428 B CN 112745428B
Authority
CN
China
Prior art keywords
formula
complex
substituted
unsubstituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911049604.4A
Other languages
Chinese (zh)
Other versions
CN112745428A (en
Inventor
高榕
郭子芳
周俊领
张师军
刘东兵
李昕阳
林洁
赖菁菁
顾元宁
安京燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinopec Beijing Research Institute of Chemical Industry
China Petroleum and Chemical Corp
Original Assignee
Sinopec Beijing Research Institute of Chemical Industry
China Petroleum and Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CN201911049604.4A priority Critical patent/CN112745428B/en
Application filed by Sinopec Beijing Research Institute of Chemical Industry, China Petroleum and Chemical Corp filed Critical Sinopec Beijing Research Institute of Chemical Industry
Priority to BR112022008300A priority patent/BR112022008300A2/en
Priority to JP2022525809A priority patent/JP2023500504A/en
Priority to PCT/CN2020/125433 priority patent/WO2021083358A1/en
Priority to US17/755,542 priority patent/US12428505B2/en
Priority to EP20880543.2A priority patent/EP4053174A4/en
Priority to CA3159659A priority patent/CA3159659A1/en
Priority to KR1020227018606A priority patent/KR20220097939A/en
Publication of CN112745428A publication Critical patent/CN112745428A/en
Application granted granted Critical
Publication of CN112745428B publication Critical patent/CN112745428B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F210/00Copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
    • C08F210/02Ethene
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2410/00Features related to the catalyst preparation, the catalyst use or to the deactivation of the catalyst
    • C08F2410/03Multinuclear procatalyst, i.e. containing two or more metals, being different or not

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明涉及一种烯烃‑烯烃醇共聚物的制备方法及由所述方法制备的烯烃‑烯烃醇共聚物。该烯烃‑烯烃醇共聚物的制备方法中使用的催化剂包括式I所示的胺基亚胺类配合物。根据本发明的制备方法制得的球形和/或类球形聚合物在工业应用中具有良好的前景。

Figure DDA0002255002140000011

Figure 201911049604

The present invention relates to a preparation method of an olefin-olefin alcohol copolymer and an olefin-olefin alcohol copolymer prepared by the method. The catalyst used in the preparation method of the olefin-olefin alcohol copolymer comprises the aminoimine complex shown in formula I. The spherical and/or spherical-like polymers prepared according to the preparation method of the present invention have good prospects in industrial applications.

Figure DDA0002255002140000011

Figure 201911049604

Description

一种烯烃-烯烃醇共聚物的制备方法A kind of preparation method of olefin-olefin alcohol copolymer

技术领域technical field

本发明属于高分子聚合物制备领域,具体涉及一种烯烃-烯烃醇共聚物的制备方法。The invention belongs to the field of high molecular polymer preparation, in particular to a preparation method of an olefin-olefin alcohol copolymer.

背景技术Background technique

聚烯烃产品价格低廉,性能优异,应用范围广。在保留聚烯烃原有优异的物理化学性能的条件下,将极性基团通过化学合成方法引入聚烯烃分子链中,可以改善其化学惰性、印染性、润湿性及与其它材料的相容性,赋予其原料不具备的新特性。目前工业上大多使用高压自由基聚合来促使烯烃与极性单体的直接共聚,如乙烯-醋酸乙烯酯、乙烯-甲基丙烯酸甲酯、乙烯-丙烯酸共聚物都在使用这种方法。虽然用高压自由基共聚可以直接把共聚极性单体引入聚烯烃链中,但该方法需要高温高压条件,能量消耗高,设备费用昂贵。Polyolefin products are inexpensive, excellent in performance and have a wide range of applications. Under the condition of retaining the original excellent physical and chemical properties of polyolefin, the introduction of polar groups into the molecular chain of polyolefin through chemical synthesis can improve its chemical inertness, printing and dyeing properties, wettability and compatibility with other materials properties, giving it new properties that its raw materials do not possess. At present, high-pressure free radical polymerization is mostly used in industry to promote the direct copolymerization of olefins and polar monomers, such as ethylene-vinyl acetate, ethylene-methyl methacrylate, and ethylene-acrylic acid copolymers. Although high-pressure free radical copolymerization can directly introduce copolymerized polar monomers into the polyolefin chain, this method requires high temperature and high pressure conditions, high energy consumption, and expensive equipment.

乙烯-乙烯醇(EVOH或EVAL)共聚物是一种集乙烯聚合物的加工性和乙烯醇聚合物的隔气性于一体的新型高分子材料,是目前世界上工业化生产的三大阻隔树脂之一,被广泛地用于包装食品、医疗用溶液和其他产品。由于乙烯醇不能以单体形式独立存在,因此其通常是由乙烯-醋酸乙烯酯通过自由基聚合,共聚物经过醇解反应制得,但其醇解过程中需要使用大量的溶剂,而且最终的皂化产物中含有大量的醋酸及碱金属盐等杂质,需要大量的水进行洗涤。Ethylene-vinyl alcohol (EVOH or EVAL) copolymer is a new type of polymer material that integrates the processability of ethylene polymers and the gas barrier properties of vinyl alcohol polymers. It is one of the three major barrier resins industrially produced in the world. One, it is widely used in packaging food, medical solutions and other products. Since vinyl alcohol cannot exist independently in the form of monomers, it is usually prepared by free radical polymerization of ethylene-vinyl acetate, and the copolymer is obtained by alcoholysis reaction. However, a large amount of solvent needs to be used in the alcoholysis process, and the final The saponification product contains a large amount of impurities such as acetic acid and alkali metal salts, and requires a large amount of water for washing.

配位催化共聚作为一种常温常压的聚合物制备技术,因其在降低能耗,提高反应效率等方面的显著作用而受到了广泛关注。催化剂参与反应过程使得烯烃单体与极性单体的共聚反应活化能大幅度降低,从而有利于在较低的温度和压力下得到较高分子量的功能聚合物。目前,只有少量文献报导采用过渡金属配合物催化烯烃与不饱和醇共聚。但是,现有技术中无论是采用何种方法进行聚合所得聚合物为粘稠的块状固体,容易在聚合设备中结垢,给聚合物的运输、溶剂脱除、造粒等带来困难。Coordination-catalyzed copolymerization, as a polymer preparation technology at room temperature and pressure, has received extensive attention due to its significant role in reducing energy consumption and improving reaction efficiency. The participation of the catalyst in the reaction process greatly reduces the activation energy of the copolymerization reaction of olefin monomers and polar monomers, which is beneficial to obtain functional polymers with higher molecular weight at lower temperature and pressure. Currently, only a few literatures report the use of transition metal complexes to catalyze the copolymerization of olefins with unsaturated alcohols. However, in the prior art, no matter what method is used to carry out the polymerization, the polymer obtained is a viscous bulk solid, which is easy to scale in the polymerization equipment, which brings difficulties to the transportation, solvent removal, and granulation of the polymer.

发明内容SUMMARY OF THE INVENTION

本发明目的之一是克服现有技术存在的不足,提供一种烯烃-烯烃醇共聚物的制备方法。本发明所提供的方法中使用的催化剂中包含新型的三核配合物。通过本发明的方法可直接得到球形和/或类球形聚合物,聚合物的形貌良好,具有良好的工业应用前景。One of the objectives of the present invention is to overcome the deficiencies of the prior art and provide a preparation method of an olefin-olefin alcohol copolymer. The catalyst used in the method provided by the present invention contains a novel trinuclear complex. Spherical and/or quasi-spherical polymers can be directly obtained by the method of the present invention, and the polymers have good morphology and good industrial application prospects.

在第一方面,本发明提供一种烯烃-烯烃醇共聚物的制备方法,其包括在催化剂和任选地链转移剂存在下使烯烃和烯烃醇发生聚合,生成所述烯烃-烯烃醇共聚物,In a first aspect, the present invention provides a method for preparing an olefin-olefin alcohol copolymer, which comprises polymerizing an olefin and an olefin alcohol in the presence of a catalyst and optionally a chain transfer agent to generate the olefin-olefin alcohol copolymer ,

其中,所述催化剂包括主催化剂和任选地助催化剂,所述主催化剂包括如式I所示的胺基亚胺类配合物:Wherein, the catalyst includes a main catalyst and an optional co-catalyst, and the main catalyst includes an aminoimine complex as shown in formula I:

Figure BDA0002255002120000021
Figure BDA0002255002120000021

式I中,R1和R2相同或不同,独立选自含取代基或不含取代基的C1-C30烃基;R21-R24相同或不同,各自独立地选自氢、卤素、羟基、含取代基或不含取代基的C1-C20烃基和含取代基或不含取代基的C1-C20烃氧基;R21-R24任选地相互成环,优选R21和R22形成苯环,所述苯环可带有取代基;R5选自氢和含取代基或不含取代基的C1-C20烃基;R11选自含取代基或不含取代基的C1-C20烃基;Y选自VIA族非金属原子;M为Ⅷ族金属;X选自卤素、含取代基或不含取代基的C1-C10烃基和含取代基或不含取代基的C1-C10烃氧基。In formula I, R 1 and R 2 are the same or different, and are independently selected from C1-C30 hydrocarbon groups with or without substituents; R 21 -R 24 are the same or different, and are independently selected from hydrogen, halogen, hydroxyl, Substituted or unsubstituted C1-C20 hydrocarbyl and substituted or unsubstituted C1-C20 hydrocarbyloxy; R 21 -R 24 optionally form a ring with each other, preferably R 21 and R 22 form benzene Ring, the benzene ring may have a substituent; R 5 is selected from hydrogen and C1-C20 hydrocarbon group with or without substituent; R 11 is selected from C1-C20 hydrocarbon group with or without substituent; Y is selected from non-metal atoms of Group VIA; M is a metal of Group VIII; X is selected from halogen, C1-C10 hydrocarbyl with or without substituents, and C1-C10 hydrocarbyloxy with or without substituents.

根据本发明的一些实施方式,R1和R2选自含取代基或不含取代基的C1-C20烷基和或含取代基或不含取代基的C6-C20芳基,优选地,R1和/或R2是如式A所示的基团:According to some embodiments of the present invention, R 1 and R 2 are selected from substituted or unsubstituted C1-C20 alkyl groups and or substituted or unsubstituted C6-C20 aryl groups, preferably, R 1 and/or R 2 are groups of formula A:

Figure BDA0002255002120000031
Figure BDA0002255002120000031

式A中,R1-R5相同或不同,各自独立地选自氢、卤素、羟基、含取代基或不含取代基的C1-C20烷基、含取代基或不含取代基的C2-C20烯基、含取代基或不含取代基的C2-C20炔基、含取代基或不含取代基的C1-C20烷氧基、含取代基或不含取代基的C2-C20烯氧基、含取代基或不含取代基的C2-C20炔氧基、含取代基或不含取代基的C6-C20芳基、含取代基或不含取代基的C7-C20芳烷基、含取代基或不含取代基的C7-C20烷芳基、取代基或不含取代基的C6-C20芳氧基、含取代基或不含取代基的C7-C20芳烷氧基和含取代基或不含取代基的C7-C20烷芳氧基;R1-R5任选地相互成环。In formula A, R 1 -R 5 are the same or different, each independently selected from hydrogen, halogen, hydroxyl, C1-C20 alkyl with or without substituent, C2- with or without substituent C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C1-C20 alkoxy, substituted or unsubstituted C2-C20 alkenyloxy , C2-C20 alkynyloxy with or without substituent, C6-C20 aryl with or without substituent, C7-C20 aralkyl with or without substituent, C7-C20 with substituent substituted or unsubstituted C7-C20 alkaryl, substituted or unsubstituted C6-C20 aryloxy, substituted or unsubstituted C7-C20 aralkoxy and substituted or Unsubstituted C7-C20 alkaryloxy; R 1 -R 5 optionally form rings with each other.

根据本发明的一些实施方式,式A中,R1-R5相同或不同,各自独立地选自氢、卤素、羟基、含取代基或不含取代基的C1-C10烷基、含取代基或不含取代基的C2-C10烯基、含取代基或不含取代基的C2-C10炔基、含取代基或不含取代基的C1-C10烷氧基、含取代基或不含取代基的C2-C10烯氧基、含取代基或不含取代基的C2-C10炔氧基、含取代基或不含取代基的C6-C15芳基、含取代基或不含取代基的C7-C15芳烷基、含取代基或不含取代基的C7-C15烷芳基、取代基或不含取代基的C6-C15芳氧基、含取代基或不含取代基的C7-C15芳烷氧基和含取代基或不含取代基的C7-C15烷芳氧基。According to some embodiments of the present invention, in formula A, R 1 -R 5 are the same or different, and each is independently selected from hydrogen, halogen, hydroxyl, C1-C10 alkyl with or without substituent, or unsubstituted C2-C10 alkenyl, substituted or unsubstituted C2-C10 alkynyl, substituted or unsubstituted C1-C10 alkoxy, substituted or unsubstituted C2-C10 alkenyloxy, substituted or unsubstituted C2-C10 alkynyloxy, substituted or unsubstituted C6-C15 aryl, substituted or unsubstituted C7 -C15 aralkyl, substituted or unsubstituted C7-C15 alkaryl, substituted or unsubstituted C6-C15 aryloxy, substituted or unsubstituted C7-C15 aryl Alkoxy and substituted or unsubstituted C7-C15 alkaryloxy groups.

根据本发明的一些实施方式,R1-R5相同或不同,各自独立地选自氢、卤素、羟基、含取代基或不含取代基的C1-C6烷基、含取代基或不含取代基的C2-C6烯基、含取代基或不含取代基的C2-C6炔基、含取代基或不含取代基的C1-C6烷氧基、含取代基或不含取代基的C2-C6烯氧基、含取代基或不含取代基的C2-C6炔氧基、含取代基或不含取代基的C6-C10芳基、含取代基或不含取代基的C7-C10芳烷基、含取代基或不含取代基的C7-C10烷芳基、取代基或不含取代基的C6-C10芳氧基、含取代基或不含取代基的C7-C10芳烷氧基和含取代基或不含取代基的C7-C10烷芳氧基。According to some embodiments of the present invention, R 1 -R 5 are the same or different, each independently selected from hydrogen, halogen, hydroxyl, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C2-C6 alkenyl, substituted or unsubstituted C2-C6 alkynyl, substituted or unsubstituted C1-C6 alkoxy, substituted or unsubstituted C2- C6 alkenyloxy, substituted or unsubstituted C2-C6 alkynyloxy, substituted or unsubstituted C6-C10 aryl, substituted or unsubstituted C7-C10 aralkane substituted or unsubstituted C7-C10 alkaryl, substituted or unsubstituted C6-C10 aryloxy, substituted or unsubstituted C7-C10 aralkoxy and Substituted or unsubstituted C7-C10 alkaryloxy.

根据本发明的一些实施方式,M选自镍和钯。According to some embodiments of the present invention, M is selected from nickel and palladium.

根据本发明的一些实施方式,Y选自O和S。According to some embodiments of the present invention, Y is selected from O and S.

根据本发明的一些实施方式,X选自卤素、含取代基或不含取代基的C1-C10烷基和含取代基或不含取代基的C1-C10烷氧基,优选选自卤素、含取代基或不含取代基的C1-C6烷基和含取代基或不含取代基的C1-C6烷氧基。According to some embodiments of the present invention, X is selected from halogen, substituted or unsubstituted C1-C10 alkyl and substituted or unsubstituted C1-C10 alkoxy, preferably selected from halogen, substituted or unsubstituted C1-C10 alkoxy Substituted or unsubstituted C1-C6 alkyl and substituted or unsubstituted C1-C6 alkoxy.

根据本发明的一些实施方式,R11选自含取代基或不含取代基的C1-C20烷基,优选为含取代基或不含取代基的C1-C10烷基,更优选为含取代基或不含取代基的C1-C6烷基。According to some embodiments of the present invention, R 11 is selected from substituted or unsubstituted C1-C20 alkyl, preferably substituted or unsubstituted C1-C10 alkyl, more preferably substituted or C1-C6 alkyl without substituents.

根据本发明的一些实施方式,R5选自含取代基或不含取代基的C1-C20烷基、含取代基或不含取代基的C6-C20芳基、含取代基或不含取代基的C7-C20芳烷基和含取代基或不含取代基的C7-C20烷芳基;优选地,R5选自含取代基或不含取代基的C1-C10烷基、含取代基或不含取代基的C6-C10芳基、含取代基或不含取代基的C7-C15芳烷基和含取代基或不含取代基的C7-C15烷芳基,更优选地,R5选自含取代基或不含取代基的C1-C6烷基,如甲基、乙基、丙基或丁基。According to some embodiments of the present invention, R 5 is selected from substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C6-C20 aryl, substituted or unsubstituted C7-C20 aralkyl group and C7-C20 alkaryl group with or without substituent group; preferably, R 5 is selected from C1-C10 alkyl group with or without substituent group, with substituent group or Unsubstituted C6-C10 aryl, substituted or unsubstituted C7-C15 aralkyl and substituted or unsubstituted C7 - C15 alkaryl, more preferably, R From substituted or unsubstituted C1-C6 alkyl such as methyl, ethyl, propyl or butyl.

根据本发明的一些实施方式,R21-R24相同或不同,各自独立地选自氢、卤素、羟基、含取代基或不含取代基的C1-C20烷基、含取代基或不含取代基的C2-C20烯基、含取代基或不含取代基的C2-C20炔基、含取代基或不含取代基的C1-C20烷氧基、含取代基或不含取代基的C2-C20烯氧基、含取代基或不含取代基的C2-C20炔氧基、含取代基或不含取代基的C6-C20芳基、含取代基或不含取代基的C7-C20芳烷基、含取代基或不含取代基的C7-C20烷芳基、取代基或不含取代基的C6-C20芳氧基、含取代基或不含取代基的C7-C20芳烷氧基和含取代基或不含取代基的C7-C20烷芳氧基;R21-R24任选地相互成环。According to some embodiments of the present invention, R 21 -R 24 are the same or different, and are each independently selected from hydrogen, halogen, hydroxyl, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C1-C20 alkoxy, substituted or unsubstituted C2- C20 alkenyloxy, substituted or unsubstituted C2-C20 alkynyloxy, substituted or unsubstituted C6-C20 aryl, substituted or unsubstituted C7-C20 aralkane substituted or unsubstituted C7-C20 alkaryl, substituted or unsubstituted C6-C20 aryloxy, substituted or unsubstituted C7-C20 aralkoxy and Substituted or unsubstituted C7-C20 alkaryloxy; R 21 -R 24 optionally form a ring with each other.

根据本发明的一些实施方式,R21-R24相同或不同,各自独立地选自氢、卤素、羟基、含取代基或不含取代基的C1-C10烷基、含取代基或不含取代基的C2-C10烯基、含取代基或不含取代基的C2-C10炔基、含取代基或不含取代基的C1-C10烷氧基、含取代基或不含取代基的C2-C10烯氧基、含取代基或不含取代基的C2-C10炔氧基、含取代基或不含取代基的C6-C15芳基、含取代基或不含取代基的C7-C15芳烷基、含取代基或不含取代基的C7-C15烷芳基、取代基或不含取代基的C6-C15芳氧基、含取代基或不含取代基的C7-C15芳烷氧基和含取代基或不含取代基的C7-C15烷芳氧基。According to some embodiments of the present invention, R 21 -R 24 are the same or different, each independently selected from hydrogen, halogen, hydroxyl, substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C2-C10 alkenyl, substituted or unsubstituted C2-C10 alkynyl, substituted or unsubstituted C1-C10 alkoxy, substituted or unsubstituted C2- C10 alkenyloxy, substituted or unsubstituted C2-C10 alkynyloxy, substituted or unsubstituted C6-C15 aryl, substituted or unsubstituted C7-C15 aralkane substituted or unsubstituted C7-C15 alkaryl, substituted or unsubstituted C6-C15 aryloxy, substituted or unsubstituted C7-C15 aralkoxy and Substituted or unsubstituted C7-C15 alkaryloxy.

根据本发明的一些实施方式,R21-R24相同或不同,各自独立地选自氢、C1-C10烷基、卤代的C1-C10烷基、C1-C10烷氧基、卤代的C1-C10烷氧基和卤素,更优选选自氢、C1-C6烷基、卤代的C1-C6烷基、C1-C6烷氧基、卤代的C1-C6烷氧基和卤素。According to some embodiments of the present invention, R 21 -R 24 are the same or different, each independently selected from hydrogen, C1-C10 alkyl, halogenated C1-C10 alkyl, C1-C10 alkoxy, halogenated C1 -C10 alkoxy and halogen, more preferably selected from hydrogen, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkoxy and halogen.

根据本发明的一些实施方式,所述取代基选自卤素、羟基、C1-C10烷基、卤代的C1-C10烷基、C1-C10烷氧基和卤代的C1-C10烷氧基;所述取代基优选选自所述取代基选自卤素、羟基、C1-C6烷基、卤代的C1-C6烷基、C1-C6烷氧基和卤代的C1-C6烷氧基。According to some embodiments of the present invention, the substituent is selected from the group consisting of halogen, hydroxy, C1-C10 alkyl, halogenated C1-C10 alkyl, C1-C10 alkoxy, and halogenated C1-C10 alkoxy; The substituents are preferably selected from the group consisting of halogen, hydroxy, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy and halogenated C1-C6 alkoxy.

根据本发明的一些实施方式,所述C1-C6烷基选自甲基、乙基、正丙基、异丙基、正丁基和异丁基、正戊基、异戊基、正己基、异己基,3,3-二甲基丁基。According to some embodiments of the present invention, the C1-C6 alkyl group is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl and isobutyl, n-pentyl, isopentyl, n-hexyl, Isohexyl, 3,3-dimethylbutyl.

根据本发明的一些实施方式,所述C1-C6烷氧基选自甲氧基、乙氧基、正丙氧基、异丙氧基、正丁氧基和异丁氧基、正戊氧基、异戊氧基、正己氧基、异己氧基,3,3-二甲基丁氧基。According to some embodiments of the present invention, the C1-C6 alkoxy group is selected from methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy and isobutoxy, n-pentoxy , isopentyloxy, n-hexyloxy, isohexyloxy, 3,3-dimethylbutoxy.

根据本发明的一些实施方式,所述卤素选自氟、氯、溴和碘。According to some embodiments of the present invention, the halogen is selected from the group consisting of fluorine, chlorine, bromine and iodine.

根据本发明的一些实施方式,所述胺基亚胺配合物的结构如式IA所示的子结构:According to some embodiments of the present invention, the structure of the aminoimine complex is shown in the substructure of formula IA:

Figure BDA0002255002120000051
Figure BDA0002255002120000051

其中,R31-R34与式I中R22-R24具有相同定义,优选地,R33和R34为氢。Wherein, R 31 -R 34 have the same definitions as R 22 -R 24 in formula I, preferably, R 33 and R 34 are hydrogen.

根据本发明的一些实施方式,所述胺基亚胺类配合物如式II所示:According to some embodiments of the present invention, the aminoimine complex is shown in formula II:

Figure BDA0002255002120000061
Figure BDA0002255002120000061

式II所示的胺基亚胺类配合物的示例包括但不限于:Examples of aminoimine complexes represented by formula II include, but are not limited to:

1)式II所示配合物,其中R1=R3=R4=R6=异丙基,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;1) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =isopropyl, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

2)式II所示配合物,其中R1=R3=R4=R6=Et,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;2) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Et, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

3)式II所示配合物,其中R1=R3=R4=R6=Me,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;3) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

4)式II所示配合物,其中R1-R6=Me,R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;4) The complex represented by formula II, wherein R 1 -R 6 =Me, R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O , X=Br;

5)式II所示配合物,其中R1=R3=R4=R6=Br,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;5) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Br, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

6)式II所示配合物,其中R1=R3=R4=R6=Cl,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;6) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Cl, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

7)式II所示配合物,其中R1=R3=R4=R6=F,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;7) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =F, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

8)式II所示配合物,其中R1=R3=R4=R6=异丙基,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;8) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =isopropyl, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =R 11 =Et, M=Ni, Y=O, X=Br;

9)式II所示配合物,其中R1=R3=R4=R6=Et,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;9) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Et, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =R 11 = Et, M=Ni, Y=O, X=Br;

10)式II所示配合物,其中R1=R3=R4=R6=Me,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;10) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =R 11 = Et, M=Ni, Y=O, X=Br;

11)式II所示配合物,其中R1-R6=Me,R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;11) The complex represented by formula II, wherein R 1 -R 6 =Me, R 7 -R 10 =R 21 =R 22 =H, R 5 =R 11 =Et, M=Ni, Y=O, X= Br;

12)式II所示配合物,其中R1=R3=R4=R6=Br,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;12) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Br, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =R 11 = Et, M=Ni, Y=O, X=Br;

13)式II所示配合物,其中R1=R3=R4=R6=Cl,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;13) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Cl, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =R 11 = Et, M=Ni, Y=O, X=Br;

14)式II所示配合物,其中R1=R3=R4=R6=F,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;14) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =F, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =R 11 = Et, M=Ni, Y=O, X=Br;

15)式II所示配合物,其中R1=R3=R4=R6=异丙基,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;15) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =isopropyl, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

16)式II所示配合物,其中R1=R3=R4=R6=Et,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;16) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Et, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

17)式II所示配合物,其中R1=R3=R4=R6=Me,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;17) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

18)式II所示配合物,其中R1-R6=Me,R7-R10=R21=R22=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;18) The complex represented by formula II, wherein R 1 -R 6 =Me, R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =isobutyl, M =Ni,Y =O, X=Br;

19)式II所示配合物,其中R1=R3=R4=R6=Br,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;19) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Br, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

20)式II所示配合物,其中R1=R3=R4=R6=Cl,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;20) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Cl, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

21)式II所示配合物,其中R1=R3=R4=R6=F,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;21) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =F, R 2 =R 5 =R 7 -R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

22)式II所示配合物,其中R1=R3=R4=R6=异丙基,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;22) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =isopropyl, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

23)式II所示配合物,其中R1=R3=R4=R6=Et,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;23) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Et, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

24)式II所示配合物,其中R1=R3=R4=R6=Me,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;24) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

25)式II所示配合物,其中R1-R6=Me,R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;25) The complex represented by formula II, wherein R 1 -R 6 =Me, R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =Et, M =Ni , Y=O, X=Br;

26)式II所示配合物,其中R1=R3=R4=R6=Br,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;26) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Br, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

27)式II所示配合物,其中R1=R3=R4=R6=Cl,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;27) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Cl, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

28)式II所示配合物,其中R1=R3=R4=R6=F,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;28) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =F, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

29)式II所示配合物,其中R1=R3=R4=R6=异丙基,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;29) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =isopropyl, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

30)式II所示配合物,其中R1=R3=R4=R6=Et,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;30) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Et, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

31)式II所示配合物,其中R1=R3=R4=R6=Me,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;31) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

32)式II所示配合物,其中R1-R6=Me,R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;32) The complex represented by formula II, wherein R 1 -R 6 =Me, R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =isobutyl, M =Ni, Y=O, X=Br;

33)式II所示配合物,其中R1=R3=R4=R6=Br,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;33) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Br, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

34)式II所示配合物,其中R1=R3=R4=R6=Cl,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;34) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =Cl, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

35)式II所示配合物,其中R1=R3=R4=R6=F,R2=R5=R7-R10=R22=H,R21=叔丁基,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;35) The complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =F, R 2 =R 5 =R 7 -R 10 =R 22 =H, R 21 =tert-butyl, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

Figure BDA0002255002120000091
Figure BDA0002255002120000091

29)式(II’)所示配合物,其中R1=R3=R4=R6=异丙基,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;29) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =isopropyl, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

30)式(II’)所示配合物,其中R1=R3=R4=R6=Et,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;30) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Et, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

31)式(II’)所示配合物,其中R1=R3=R4=R6=Me,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;31) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

32)式(II’)所示配合物,其中R1-R6=Me,R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;32) The complex represented by formula (II'), wherein R 1 -R 6 =Me, R 7 -R 10 =R 31 =R 32 =H, R 5 =CH 3 , R 11 =Et, M =Ni, Y=O, X=Br;

33)式(II’)所示配合物,其中R1=R3=R4=R6=Br,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;33) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Br, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

34)式(II’)所示配合物,其中R1=R3=R4=R6=Cl,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;34) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Cl, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

35)式(II’)所示配合物,其中R1=R3=R4=R6=F,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;35) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =F, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

36)式(II’)所示配合物,其中R1=R3=R4=R6=异丙基,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;36) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =isopropyl, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

37)式(II’)所示配合物,其中R1=R3=R4=R6=Et,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;37) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Et, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

38)式(II’)所示配合物,其中R1=R3=R4=R6=Me,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;38) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

39)式(II’)所示配合物,其中R1-R6=Me,R7-R10=R31=R32=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;39) The complex represented by formula (II'), wherein R 1 -R 6 =Me, R 7 -R 10 =R 31 =R 32 =H, R 5 =CH 3 , R 11 =isobutyl, M= Ni, Y=O, X=Br;

40)式(II’)所示配合物,其中R1=R3=R4=R6=Br,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;40) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Br, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

41)式(II’)所示配合物,其中R1=R3=R4=R6=Cl,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;41) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Cl, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

42)式(II’)所示配合物,其中R1=R3=R4=R6=F,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;42) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =F, R 2 =R 5 =R 7 -R 10 =R 31 =R 32 =H, R 5 = CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

43)式(II’)所示配合物,其中R1=R3=R4=R6=异丙基,R2=R5=R7-R10=H R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;43) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =isopropyl, R 2 =R 5 =R 7 -R 10 =HR 31 =R 32 =R 11 = Et, R 5 =CH 3 , M=Ni, Y=O, X=Br;

44)式(II’)所示配合物,其中R1=R3=R4=R6=Et,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;44) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Et, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =R 11 = Et, R 5 =CH 3 , M=Ni, Y=O, X=Br;

45)式(II’)所示配合物,其中R1=R3=R4=R6=Me,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;45) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =R 11 = Et, R 5 =CH 3 , M=Ni, Y=O, X=Br;

46)式(II’)所示配合物,其中R1-R6=Me,R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;46) The complex represented by formula (II'), wherein R 1 -R 6 =Me, R 7 -R 10 =H, R 31 =R 32 =R 11 =Et, R 5 =CH 3 , M =Ni, Y=O, X=Br;

47)式(II’)所示配合物,其中R1=R3=R4=R6=Br,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;47) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Br, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =R 11 = Et, R 5 =CH 3 , M=Ni, Y=O, X=Br;

48)式(II’)所示配合物,其中R1=R3=R4=R6=Cl,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;48) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Cl, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =R 11 = Et, R 5 =CH 3 , M=Ni, Y=O, X=Br;

49式(II’)所示配合物,其中R1=R3=R4=R6=F,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;49 The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =F, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =R 11 =Et , R 5 =CH 3 , M=Ni, Y=O, X=Br;

50)式(II’)所示配合物,其中R1=R3=R4=R6=异丙基,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;50) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =isopropyl, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =R 11 =Et, R 5 =CH 3 , M=Ni, Y=O, X=Br;

51)式(II’)所示配合物,其中R1=R3=R4=R6=Et,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;51) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Et, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =Et, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

52)式(II’)所示配合物,其中R1=R3=R4=R6=Me,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;52) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =Et, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

53)式(II’)所示配合物,其中R1-R6=Me,R7-R10=H,R31=R32=Et,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;53) The complex represented by formula (II'), wherein R 1 -R 6 =Me, R 7 -R 10 =H, R 31 =R 32 =Et, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

54)式(II’)所示配合物,其中R1=R3=R4=R6=Br,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;54) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Br, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =Et, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

55)式(II’)所示配合物,其中R1=R3=R4=R6=Cl,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;55) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =Cl, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =Et, R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

56)式(II’)所示配合物,其中R1=R3=R4=R6=F,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br。56) The complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =F, R 2 =R 5 =R 7 -R 10 =H, R 31 =R 32 =Et, R 5 = CH3 , R11 =isobutyl, M=Ni, Y=O, X=Br.

根据本发明的一些实施方式,所述烯烃醇选自式G所示的烯烃醇中的一种或多种:According to some embodiments of the present invention, the alkene alcohol is selected from one or more of the alkene alcohols shown in formula G:

Figure BDA0002255002120000111
Figure BDA0002255002120000111

式G中,L1-L3各自独立地选自H和含或不含取代基的C1-C30烷基,L4为具有侧基的C1-C30亚烷基。In formula G, L 1 -L 3 are each independently selected from H and C 1 -C 30 alkyl groups with or without substituents, and L 4 is C 1 -C 30 alkylene groups with pendant groups.

根据本发明的一些实施方式,所述共聚物中,衍生自式G所示的烯烃醇的结构单元的含量为0.4-10.0mol%。According to some embodiments of the present invention, the content of the structural unit derived from the olefin alcohol represented by formula G in the copolymer is 0.4-10.0 mol%.

根据本发明的一些实施方式,式G中,L1和L2为H。According to some embodiments of the present invention, in formula G, L 1 and L 2 are H.

根据本发明的一些实施方式,式G中,L3为H或C1-C30烷基。According to some embodiments of the present invention, in formula G, L 3 is H or C 1 -C 30 alkyl.

根据本发明的一些实施方式,式G中,L4为具有侧基的C1-C30亚烷基。According to some embodiments of the present invention, in formula G, L 4 is a C 1 -C 30 alkylene group having a pendant group.

根据本发明的一些实施方式,式G中,L3为H或C1-C20烷基。According to some embodiments of the present invention, in formula G, L 3 is H or C 1 -C 20 alkyl.

根据本发明的一些实施方式,式G中,L4为具有侧基的C1-C20亚烷基。According to some embodiments of the present invention, in formula G, L 4 is a C 1 -C 20 alkylene group having a pendant group.

根据本发明的一些实施方式,式G中,L3为H或C1-C10烷基。According to some embodiments of the present invention, in formula G, L 3 is H or C 1 -C 10 alkyl.

根据本发明的一些实施方式,式G中,L4为具有侧基的C1-C10亚烷基。According to some embodiments of the present invention, in formula G, L 4 is a C 1 -C 10 alkylene group having a pendant group.

根据本发明的一些实施方式,式G中,L4为具有侧基的C1-C6亚烷基。According to some embodiments of the present invention, in formula G, L 4 is a C 1 -C 6 alkylene group having a pendant group.

根据本发明的一些实施方式,L1-L3中所述取代基选自卤素、C1-C10烷基、C1-C10烷氧基、C6-C10芳基、氰基和羟基中的一种或多种。According to some embodiments of the present invention, the substituents in L 1 -L 3 are selected from halogen, C 1 -C 10 alkyl, C 1 -C 10 alkoxy, C 6 -C 10 aryl, cyano and one or more of the hydroxyl groups.

根据本发明的一些实施方式,L1-L3中所述取代基选自C1-C6烷基、卤素和C1-C6烷氧基中的一种或多种。According to some embodiments of the present invention, the substituents in L 1 -L 3 are selected from one or more of C1-C6 alkyl, halogen and C1-C6 alkoxy.

根据本发明的一些实施方式,L4中所述侧基选自卤素、C6-C20芳基、C1-C20烷基和C1-C20烷氧基中的一种或多种,所述C6-C20芳基、C1-C20烷基和C1-C20烷氧基任选地被取代基取代,优选所述取代基选自卤素、C1-C10烷基、C1-C10烷氧基、C6-C10芳基和羟基中的一种或多种。According to some embodiments of the present invention, the side group in L4 is selected from one or more of halogen, C 6 -C 20 aryl, C 1 -C 20 alkyl and C 1 -C 20 alkoxy, The C 6 -C 20 aryl, C 1 -C 20 alkyl and C 1 -C 20 alkoxy groups are optionally substituted with substituents, preferably the substituents are selected from halogen, C 1 -C 10 alkyl , one or more of C 1 -C 10 alkoxy, C 6 -C 10 aryl and hydroxyl.

根据本发明的优选实施方式,所述L4中的侧基选自卤素、C6-C20芳基、C1-C20烷基、羟基取代的C1-C20烷基和烷氧基取代的C1-C20烷基中的一种或多种;优选地,所述侧基选自卤素、C6-C20芳基、C1-C10烷基、羟基取代的C1-C10烷基和烷氧基取代的C1-10烷基中的一种或多种;更优选地,所述侧基选自卤素、苯基、C1-C6烷基和羟基取代的C1-C6烷基中的一种或多种,所述C1-C6烷基包括甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基、戊基和己基。According to a preferred embodiment of the present invention, the side group in L 4 is selected from halogen, C 6 -C 20 aryl, C 1 -C 20 alkyl, hydroxy-substituted C 1 -C 20 alkyl and alkoxy One or more of substituted C 1 -C 20 alkyl groups; preferably, the side group is selected from halogen, C 6 -C 20 aryl, C 1 -C 10 alkyl, hydroxy substituted C 1 - One or more of C 10 alkyl and alkoxy substituted C 1-10 alkyl; more preferably, the side group is selected from halogen, phenyl, C 1 -C 6 alkyl and hydroxy substituted One or more of C 1 -C 6 alkyl groups, the C 1 -C 6 alkyl groups include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl , pentyl and hexyl.

根据本发明的优选实施方式,式G中,L1和L2为H,L3为H或C1-C30烷基,L4为具有侧基的C1-C30亚烷基;所述C1-C30烷基任选地被取代基取代,优选所述取代基选自卤素、C1-C10烷基、C1-C10烷氧基、C6-C10芳基、氰基和羟基中的一种或多种。According to a preferred embodiment of the present invention, in formula G, L 1 and L 2 are H, L 3 is H or C 1 -C 30 alkyl, and L 4 is C 1 -C 30 alkylene with side groups; The C 1 -C 30 alkyl group is optionally substituted with a substituent, preferably the substituent is selected from halogen, C 1 -C 10 alkyl, C 1 -C 10 alkoxy, C 6 -C 10 aryl, One or more of cyano and hydroxyl.

根据本发明的优选实施方式,式G中,L1和L2为H,L3为H、C1-C10烷基或卤素取代的C1-C10烷基,优选L3为H或C1-C10烷基;L4为具有侧基的C1-C20亚烷基,例如L4为具有侧基的亚甲基、具有侧基的亚乙基、具有侧基的亚丙基、具有侧基的亚丁基、具有侧基的C5亚烷基、具有侧基的C6亚烷基、具有侧基的C7亚烷基、具有侧基的C8亚烷基、具有侧基的C9亚烷基、具有侧基的C10亚烷基、具有侧基的C12亚烷基、具有侧基的C14亚烷基、具有侧基的C18亚烷基、具有侧基的C20亚烷基,优选为具有侧基的C1-C10亚烷基。According to a preferred embodiment of the present invention, in formula G, L 1 and L 2 are H, L 3 is H, C 1 -C 10 alkyl or halogen-substituted C 1 -C 10 alkyl, preferably L 3 is H or C 1 -C 10 alkyl group; L 4 is C 1 -C 20 alkylene group with side group, for example L 4 is methylene group with side group, ethylene group with side group, propylene with side group group, butylene with side group, C5 alkylene with side group, C6 alkylene with side group, C7 alkylene with side group, C8 alkylene with side group, with side group C 9 alkylene with side groups, C 10 alkylene with side groups, C 12 alkylene with side groups, C 14 alkylene with side groups, C 18 alkylene with side groups, C 18 alkylene with side groups Pendant C 20 alkylene groups, preferably C 1 -C 10 alkylene groups with pendant groups.

根据本发明的优选实施方式,式G中,L1和L2为H,L3为H或C1-6烷基;L4为具有侧基的C1-C10亚烷基。According to a preferred embodiment of the present invention, in formula G, L 1 and L 2 are H, L 3 is H or C 1-6 alkyl; L 4 is C 1 -C 10 alkylene with side groups.

本发明中,Cn亚烷基的碳数n是指直链上C的个数,不包含侧基上C的数目,例如,亚异丙基(-CH2-CH(CH3)-)在本文中叫作具有侧基(甲基)的C2亚烷基。In the present invention, the carbon number n of the Cn alkylene group refers to the number of C on the straight chain, excluding the number of C on the side group, for example, isopropylidene (-CH 2 -CH(CH 3 )-) is in the It is referred to herein as a C2 alkylene group with a pendant (methyl) group.

根据本发明的优选实施方式,式G所示的烯烃醇的具体实例包括但不限于:2-甲基-3-丁烯-1-醇、2-乙基-3-丁烯-1-醇、1,1-二苯基-3-丁烯-1-醇、2-甲基-3-丁烯-2-醇、2,2-二甲基-3-丁烯-1-醇、3-甲基-1-戊烯-3-醇、2,4-二甲基-4-戊烯-2-醇、4-烯基-2-戊醇、4-甲基-4-戊烯-2-醇、2-甲基-4-戊烯-2-醇、2-苯基-4-戊烯-2-醇、2-烯丙六氟异丙醇、2-羟基-5-己烯、3-丁烯-2-醇、3-甲基-5-己烯-3-醇、2-甲基-2-羟基-5-己烯、1-烯丙基环己醇、2,3-二甲基-2-羟基-5-己烯、1-庚烯-4-醇、4-甲基-1-庚烯-4-醇、4-正丙基-1-庚基-4-醇、6-庚烯-3-醇、2-甲基-2-羟基-6-庚烯、5-甲基-2-羟基-6-庚烯、2-羟基-3-甲基-6-庚烯、2-羟基-3-乙基-6-庚烯、2-羟基-4-甲基-6-庚烯、2-羟基-5-甲基-6-庚烯、2,5-二甲基-1-庚烯-4-醇、2,6-二甲基-7-辛烯-2-醇、2-羟基-2,4,5-三甲基-6-庚烯、2-甲基-3-羟基-7-辛烯、3-甲基-3-羟基-6-庚烯、2-甲基-2-羟基-7-辛烯、3-甲基-3-羟基-7-辛烯、4-甲基-2-羟基-7-辛烯、4-甲基-3-羟基-7-辛烯、5-甲基-3-羟基-7-辛烯、6-甲基-3-羟基-7-辛烯、3-乙基-3-羟基-7-辛烯、1,2-二羟基-7-辛烯、2,6-二甲基-2,6-二羟基-7-辛烯、2,6-二甲基-2,3-二羟基-7-辛烯、2-甲基-2-羟基-3-氯-7-辛烯、2-甲基-2-羟基-3,5-二氯-7-辛烯、3,4-二甲基-4-羟基-8-壬烯、4-甲基-4-羟基-8-壬烯、4-乙基-4-羟基-8-壬烯、4-丙基-4-羟基-8-壬烯、7-辛烯-2-醇、3,5-二氯-2-甲基-7-辛烯-2-醇、3-氯-2-甲基-7-辛烯-2,3-二醇、和2,6-二甲基-7-辛烯-2,6-二醇。According to a preferred embodiment of the present invention, specific examples of the alkene alcohol represented by formula G include but are not limited to: 2-methyl-3-buten-1-ol, 2-ethyl-3-buten-1-ol , 1,1-diphenyl-3-buten-1-ol, 2-methyl-3-buten-2-ol, 2,2-dimethyl-3-buten-1-ol, 3 -Methyl-1-penten-3-ol, 2,4-dimethyl-4-penten-2-ol, 4-enyl-2-pentenol, 4-methyl-4-pentene- 2-ol, 2-methyl-4-penten-2-ol, 2-phenyl-4-penten-2-ol, 2-allylhexafluoroisopropanol, 2-hydroxy-5-hexene , 3-buten-2-ol, 3-methyl-5-hexen-3-ol, 2-methyl-2-hydroxy-5-hexene, 1-allylcyclohexanol, 2,3 -Dimethyl-2-hydroxy-5-hexene, 1-hepten-4-ol, 4-methyl-1-hepten-4-ol, 4-n-propyl-1-heptyl-4- Alcohol, 6-hepten-3-ol, 2-methyl-2-hydroxy-6-heptene, 5-methyl-2-hydroxy-6-heptene, 2-hydroxy-3-methyl-6- Heptene, 2-hydroxy-3-ethyl-6-heptene, 2-hydroxy-4-methyl-6-heptene, 2-hydroxy-5-methyl-6-heptene, 2,5-di Methyl-1-hepten-4-ol, 2,6-dimethyl-7-octen-2-ol, 2-hydroxy-2,4,5-trimethyl-6-heptene, 2- Methyl-3-hydroxy-7-octene, 3-methyl-3-hydroxy-6-heptene, 2-methyl-2-hydroxy-7-octene, 3-methyl-3-hydroxy-7 -Octene, 4-methyl-2-hydroxy-7-octene, 4-methyl-3-hydroxy-7-octene, 5-methyl-3-hydroxy-7-octene, 6-methyl -3-Hydroxy-7-octene, 3-ethyl-3-hydroxy-7-octene, 1,2-dihydroxy-7-octene, 2,6-dimethyl-2,6-dihydroxy -7-octene, 2,6-dimethyl-2,3-dihydroxy-7-octene, 2-methyl-2-hydroxy-3-chloro-7-octene, 2-methyl-2 -Hydroxy-3,5-dichloro-7-octene, 3,4-dimethyl-4-hydroxy-8-nonene, 4-methyl-4-hydroxy-8-nonene, 4-ethyl -4-Hydroxy-8-nonene, 4-propyl-4-hydroxy-8-nonene, 7-octen-2-ol, 3,5-dichloro-2-methyl-7-octene- 2-ol, 3-chloro-2-methyl-7-octene-2,3-diol, and 2,6-dimethyl-7-octene-2,6-diol.

根据本发明的优选实施方式,所述助催化剂选自有机铝化合物和/或有机硼化合物。According to a preferred embodiment of the present invention, the cocatalyst is selected from organoaluminum compounds and/or organoboron compounds.

根据本发明的优选实施方式,所述有机铝化合物选自烷基铝氧烷或通式为AlRnX1 3-n的有机铝化合物(烷基铝或烷基铝卤化物),通式AlRnX1 3-n中,R为H、C1-C20的饱和或不饱和的烃基或C1-C20饱和或不饱和的烃氧基,优选为C1-C20烷基、C1-C20烷氧基、C7-C20芳烷基或C6-C20芳基;X1为卤素,优选为氯或溴;0<n≤3。所述有机铝化合物的具体实例包括但不限于:三甲基铝、三乙基铝、三异丁基铝、三正己基铝、三辛基铝、一氢二乙基铝、一氢二异丁基铝、一氯二乙基铝、一氯二异丁基铝、倍半乙基氯化铝、二氯乙基铝、甲基铝氧烷(MAO)和改性甲基铝氧烷(MMAO)。优选地,所述有机铝化合物为甲基铝氧烷(MAO)。According to a preferred embodiment of the present invention, the organoaluminum compound is selected from the group consisting of alkylaluminoxanes or organoaluminum compounds (alkylaluminum or alkylaluminum halides) of general formula AlR n X 1 3-n , general formula AlR In n X 1 3-n , R is H, C 1 -C 20 saturated or unsaturated hydrocarbon group or C 1 -C 20 saturated or unsaturated hydrocarbon oxy group, preferably C 1 -C 20 alkyl group, C 1 -C 20 alkyl group, C 1 -C 20 saturated or unsaturated hydrocarbon group 1 -C 20 alkoxy group, C 7 -C 20 aralkyl group or C 6 -C 20 aryl group; X 1 is halogen, preferably chlorine or bromine; 0<n≤3. Specific examples of the organoaluminum compound include, but are not limited to: trimethylaluminum, triethylaluminum, triisobutylaluminum, tri-n-hexylaluminum, trioctylaluminum, diethylaluminum monohydrogen, diisohydridohydrogenaluminum Butyl aluminum, diethyl aluminum monochloride, diisobutyl aluminum monochloride, sesquiethyl aluminum chloride, dichloroethyl aluminum, methylaluminoxane (MAO) and modified methylaluminoxane ( MMAO). Preferably, the organoaluminum compound is methylaluminoxane (MAO).

根据本发明的优选实施方式,所述有机硼化合物选自芳烃基硼和/或硼酸盐。所述芳烃基硼优选为取代或未取代的苯基硼,更优选为三(五氟苯基)硼。所述硼酸盐优选为N,N-二甲基苯铵四(五氟苯基)硼酸盐和/或四(五氟苯基)硼酸三苯基甲基盐。According to a preferred embodiment of the present invention, the organoboron compound is selected from aromatic boron and/or borates. The aromatic hydrocarbyl boron is preferably substituted or unsubstituted phenylboron, more preferably tris(pentafluorophenyl)boron. The borate is preferably N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate and/or triphenylmethyl tetrakis(pentafluorophenyl)borate.

根据本发明的优选实施方式,所述主催化剂在反应体系中的浓度为0.00001-100mmol/L,例如,0.00001mmol/L、0.00005mmol/L、0.0001mmol/L、0.0005mmol/L、0.001mmol/L、0.005mmol/L、0.01mmol/L、0.05mmol/L、0.1mmol/L、0.3mmol/L、0.5mmol/L、0.8mmol/L、1mmol/L、5mmol/L、8mmol/L、10mmol/L、20mmol/L、30mmol/L、50mmol/L、70mmol/L、80mmol/L、100mmol/L以及它们之间的任意值,优选为0.0001-1mmol/L,更优选为0.001-0.5mmol/L。According to a preferred embodiment of the present invention, the concentration of the main catalyst in the reaction system is 0.00001-100mmol/L, for example, 0.00001mmol/L, 0.00005mmol/L, 0.0001mmol/L, 0.0005mmol/L, 0.001mmol/L L, 0.005mmol/L, 0.01mmol/L, 0.05mmol/L, 0.1mmol/L, 0.3mmol/L, 0.5mmol/L, 0.8mmol/L, 1mmol/L, 5mmol/L, 8mmol/L, 10mmol /L, 20mmol/L, 30mmol/L, 50mmol/L, 70mmol/L, 80mmol/L, 100mmol/L and any value between them, preferably 0.0001-1mmol/L, more preferably 0.001-0.5mmol/L L.

根据本发明的优选实施方式,当所述助催化剂为有机铝化合物时,所述助催化剂中铝与所述主催化剂中M的摩尔比为(10-10000000):1,例如,10:1、20:1、50:1、100:1、200:1、300:1、500:1、700:1、800:1、1000:1、2000:1、3000:1、5000:1、10000:1、100000:1、1000000:1、10000000:1以及它们之间的任意值,优选为(10-100000):1,更优选为(100-10000):1;当所述助催化剂为有机硼化合物时,所述助催化剂中硼与所述主催化剂中M的摩尔比为(0.1-1000):1,例如,0.1:1、0.2:1、0.5:1、0.8:1、1:1、1.2:1、1.4:1、1.6:1、1.8:1、2:1、2.5:1、3:1、4:1、5:1、8:1、10:1、20:1、50:1、100:1、200:1、300:1、500:1、700:1、800:1、1000:1以及它们之间的任意值,优选为(0.1-500):1。According to a preferred embodiment of the present invention, when the co-catalyst is an organoaluminum compound, the molar ratio of aluminum in the co-catalyst to M in the main catalyst is (10-10,000,000):1, for example, 10:1, 20:1, 50:1, 100:1, 200:1, 300:1, 500:1, 700:1, 800:1, 1000:1, 2000:1, 3000:1, 5000:1, 10000: 1. 100000:1, 1000000:1, 10000000:1 and any value between them, preferably (10-100000):1, more preferably (100-10000):1; when the cocatalyst is organoboron compound, the molar ratio of boron in the cocatalyst to M in the main catalyst is (0.1-1000):1, for example, 0.1:1, 0.2:1, 0.5:1, 0.8:1, 1:1, 1.2:1, 1.4:1, 1.6:1, 1.8:1, 2:1, 2.5:1, 3:1, 4:1, 5:1, 8:1, 10:1, 20:1, 50: 1, 100:1, 200:1, 300:1, 500:1, 700:1, 800:1, 1000:1 and any value between them, preferably (0.1-500):1.

根据本发明的优选实施方式,所述烯烃包括具有2-16个碳原子的烯烃,在本发明的一些实施方式中,所述烯烃包括乙烯或具有3-16个碳原子的α-烯烃。在本发明的另一些实施方式中,所述烯烃为C3-C16环烯烃,优选为5元环或6元环。优选地,所述烯烃为为乙烯或具有3-16个碳原子的α-烯烃,更优选为乙烯或C2-C10α-烯烃,例如,乙烯、丙烯、丁烯、戊烯、己烯、庚烯和辛烯。According to preferred embodiments of the present invention, the olefins include olefins having 2-16 carbon atoms, and in some embodiments of the present invention, the olefins include ethylene or alpha-olefins having 3-16 carbon atoms. In other embodiments of the present invention, the olefin is a C 3 -C 16 cyclic olefin, preferably a 5-membered ring or a 6-membered ring. Preferably, the olefin is ethylene or an alpha-olefin having 3-16 carbon atoms, more preferably ethylene or a C 2 -C 10 alpha-olefin, eg ethylene, propylene, butene, pentene, hexene , heptene and octene.

根据本发明的优选实施方式,式G所示的烯烃醇单体在反应体系中的浓度为0.01-6000mmol/L,优选为0.1-1000mmol/L,更优选为1-500mmol/L,例如可以为1mmol/L、10mmol/L、20mmol/L、30mmol/L、50mmol/L、70mmol/L、90mmol/L、100mmol/L、200mmol/L、300mmol/L、400mmol/L、500mmol/L以及它们之间的任意值。According to a preferred embodiment of the present invention, the concentration of the alkene alcohol monomer represented by formula G in the reaction system is 0.01-6000 mmol/L, preferably 0.1-1000 mmol/L, more preferably 1-500 mmol/L, for example, it can be 1mmol/L, 10mmol/L, 20mmol/L, 30mmol/L, 50mmol/L, 70mmol/L, 90mmol/L, 100mmol/L, 200mmol/L, 300mmol/L, 400mmol/L, 500mmol/L and their any value in between.

根据本发明的优选实施方式,所述链转移剂选自烷基铝、烷基镁和烷基锌中的一种或多种。According to a preferred embodiment of the present invention, the chain transfer agent is selected from one or more of alkyl aluminum, alkyl magnesium and alkyl zinc.

根据本发明的优选实施方式,所述链转移剂为三烷基铝和/或二烷基锌,优选选自三甲基铝、三乙基铝、三异丙基铝、三异丁基铝、三正己基铝、三正辛基铝、二甲基锌和二乙基锌中的一种或多种。According to a preferred embodiment of the present invention, the chain transfer agent is trialkylaluminum and/or dialkylzinc, preferably selected from trimethylaluminum, triethylaluminum, triisopropylaluminum, triisobutylaluminum , one or more of tri-n-hexylaluminum, tri-n-octylaluminum, dimethylzinc and diethylzinc.

根据本发明的优选实施方式,所述链转移剂与主催化剂中M的摩尔比为(0.1-2000):1,例如,0.1:1、0.2:1、0.5:1、1:1、2:1、3:1、5:1、8:1、10:1、20:1、50:1、100:1、200:1、300:1、500:1、600:1、800:1、1000:1、2000:1以及它们之间的任意值,优选为(10-600):1。According to a preferred embodiment of the present invention, the molar ratio of the chain transfer agent to M in the main catalyst is (0.1-2000):1, for example, 0.1:1, 0.2:1, 0.5:1, 1:1, 2: 1, 3:1, 5:1, 8:1, 10:1, 20:1, 50:1, 100:1, 200:1, 300:1, 500:1, 600:1, 800:1, 1000:1, 2000:1 and any value in between, preferably (10-600):1.

根据本发明的优选实施方式,所述聚合在烷烃溶剂中进行,所述烷烃溶剂选自C3-C20烷烃中的一种或多种,优选选自C3-C10烷烃,例如,可以选自丁烷、异丁烷、戊烷、已烷、庚烷、辛烷和环己烷中的一种或多种,优选为己烷、庚烷和环己烷中的一种或多种。According to a preferred embodiment of the present invention, the polymerization is carried out in an alkane solvent, the alkane solvent is selected from one or more of C 3 -C 20 alkanes, preferably selected from C 3 -C 10 alkanes, for example, it can be One or more selected from butane, isobutane, pentane, hexane, heptane, octane and cyclohexane, preferably one or more of hexane, heptane and cyclohexane .

根据本发明的优选实施方式,所述烯烃醇预先经脱活泼氢预处理,优选地,使用上面所述的助催化剂或链转移剂对所述烯烃醇进行预处理以除去烯烃醇中的羟基活泼氢。优选地,在预处理的过程中,烯烃醇中的羟基与助催化剂或链转移剂的摩尔比为10:1-1:10。According to a preferred embodiment of the present invention, the alkene alcohol is pretreated by deactivation hydrogenation, preferably, the alkene alcohol is pretreated by using the above-mentioned cocatalyst or chain transfer agent to remove the reactive hydroxyl groups in the alkene alcohol hydrogen. Preferably, in the pretreatment process, the molar ratio of the hydroxyl group in the alkene alcohol to the cocatalyst or the chain transfer agent is 10:1-1:10.

根据本发明的优选实施方式,所述反应在无水无氧的条件下进行。According to a preferred embodiment of the present invention, the reaction is carried out under anhydrous and oxygen-free conditions.

根据本发明的优选实施方式,反应的条件包括:反应的温度-50℃-50℃,优选为-20-50℃,更优选为0-50℃,例如可以为0℃、10℃、20℃、30℃、40℃、50℃以及它们之间的任意数值;和/或,反应的时间为10-200min,优选为20-60min。本发明中,对反应的压力没有特别地限制,只要能使单体进行配位共聚反应即可。当烯烃为乙烯时,从降低成本以及简化聚合工艺的角度出发,在反应器中,优选乙烯的压力1-1000atm,进一步优选为1-200atm,更优选为1-50atm。本发明中,所述“反应体系”是指包括溶剂、烯烃、烯烃醇单体、催化剂以及任选地链转移剂所形成的总体。According to a preferred embodiment of the present invention, the reaction conditions include: the temperature of the reaction is -50°C-50°C, preferably -20-50°C, more preferably 0-50°C, such as 0°C, 10°C, 20°C , 30°C, 40°C, 50°C and any value therebetween; and/or, the reaction time is 10-200 min, preferably 20-60 min. In the present invention, the pressure of the reaction is not particularly limited as long as the monomer can undergo the coordination copolymerization reaction. When the olefin is ethylene, from the viewpoint of reducing cost and simplifying the polymerization process, in the reactor, the pressure of ethylene is preferably 1-1000 atm, more preferably 1-200 atm, more preferably 1-50 atm. In the present invention, the "reaction system" refers to the whole formed by including solvent, olefin, olefin alcohol monomer, catalyst and optionally chain transfer agent.

本发明还提供了上述制备方法制得的烯烃-烯烃醇共聚物,其包含球形和/或类球形聚合物。The present invention also provides the olefin-olefin alcohol copolymer prepared by the above preparation method, which comprises spherical and/or spherical-like polymers.

根据本发明的优选实施方式,所述球形和/或类球形聚合物的平均粒径为0.1-50.0mm,例如可以为0.1mm、0.5mm、1.0mm、2.0mm、3.0mm、5.0mm、8.0mm、10.0mm、15.0mm、20.0mm、25.0mm、30.0mm、35.0mm、40.0mm、45.0mm、50.0mm以及它们之间的任意值,优选为0.5-20.0mm。According to a preferred embodiment of the present invention, the spherical and/or spherical-like polymer has an average particle size of 0.1-50.0 mm, such as 0.1 mm, 0.5 mm, 1.0 mm, 2.0 mm, 3.0 mm, 5.0 mm, 8.0 mm mm, 10.0mm, 15.0mm, 20.0mm, 25.0mm, 30.0mm, 35.0mm, 40.0mm, 45.0mm, 50.0mm and any value therebetween, preferably 0.5-20.0mm.

根据本发明的优选实施方式,在所述烯烃-烯烃醇共聚物中,衍生自式G所示的烯烃醇的结构单元的含量为0.4-30.0mol%,例如可以为0.4mol%、0.5mol%、0.7mol%、0.8mol%、1.0mol%、1.5mol%、2.0mol%、5.0mol%、8.0mol%、10.0mol%、15.0mol%、20.0mol%、25.0mol%、30.0mol%以及它们之间的任意值,优选为0.7-10.0mol%。According to a preferred embodiment of the present invention, in the olefin-olefin alcohol copolymer, the content of the structural unit derived from the olefin alcohol represented by formula G is 0.4-30.0 mol %, for example, it can be 0.4 mol %, 0.5 mol % , 0.7mol%, 0.8mol%, 1.0mol%, 1.5mol%, 2.0mol%, 5.0mol%, 8.0mol%, 10.0mol%, 15.0mol%, 20.0mol%, 25.0mol%, 30.0mol% and their Any value between, preferably 0.7-10.0 mol%.

根据本发明的优选实施方式,所述烯烃-烯烃醇共聚物的重均分子量为30000-500000,优选为50000-400000。According to a preferred embodiment of the present invention, the weight average molecular weight of the olefin-olefin alcohol copolymer is 30,000-500,000, preferably 50,000-400,000.

根据本发明的优选实施方式,所述烯烃-烯烃醇共聚物的分子量分布≤4.0,例如可以为0.1、0.5、1.0、1.5、2.0、2.5、3.0、3.5、4.0以及它们之间的任意值,优选地,分子量分布为1.0-4.0。According to a preferred embodiment of the present invention, the molecular weight distribution of the olefin-olefin alcohol copolymer is less than or equal to 4.0. Preferably, the molecular weight distribution is 1.0-4.0.

本发明中,球形或类球形聚合物的粒径在本文中视为等于体积与颗粒体积相等的球体的直径。In the present invention, the particle size of a spherical or spherical-like polymer is considered herein to be equal to the diameter of a sphere having a volume equal to the volume of the particle.

根据本发明的又一方面,提供了所述的烯烃-烯烃醇共聚物作为聚烯烃材料的应用。According to another aspect of the present invention, the application of the olefin-olefin alcohol copolymer as a polyolefin material is provided.

本发明提供的用于制备烯烃-烯烃醇共聚物的方法使用的是一种新型的含三核金属配合物的催化剂。该催化剂未见报道,因此,本发明解决的技术问题是提供了一种新的烯烃-烯烃醇共聚物的制备方法。The method for preparing an olefin-olefin alcohol copolymer provided by the present invention uses a novel catalyst containing a trinuclear metal complex. The catalyst has not been reported, therefore, the technical problem solved by the present invention is to provide a new preparation method of olefin-olefin alcohol copolymer.

进一步地,本发明提供的烯烃-烯烃醇共聚物的制备方法中,通过选择反应的烯烃醇单体、催化剂以及合适的聚合工艺,无需后续的造粒等加工步骤而直接制备了形态良好的球形和/或类球形聚合物,得到的聚合产物不易在反应器中结垢,方便运输。Further, in the preparation method of the olefin-olefin alcohol copolymer provided by the present invention, by selecting the reacted olefin alcohol monomer, a catalyst and a suitable polymerization process, a spherical shape with good shape is directly prepared without subsequent processing steps such as granulation. and/or quasi-spherical polymer, the obtained polymer product is not easy to scale in the reactor and is convenient for transportation.

进一步地,本发明提供的制备烯烃-烯烃醇共聚物的方法相比现有工业中使用的制备烯烃-烯烃醇共聚物的工艺,省去了皂化反应的步骤,制备过程更加简单。Further, the method for preparing olefin-olefin alcohol copolymer provided by the present invention saves the step of saponification reaction compared with the process for preparing olefin-olefin alcohol copolymer used in the existing industry, and the preparation process is simpler.

附图说明Description of drawings

图1是本发明实施例2得到的球形和/或类球形聚合物的照片。Figure 1 is a photograph of the spherical and/or spherical-like polymer obtained in Example 2 of the present invention.

具体实施方式Detailed ways

以下结合实施例对本发明进行详细说明,但本发明并不受下述实施例限定。The present invention will be described in detail below with reference to the examples, but the present invention is not limited by the following examples.

本发明中所使用的分析表征仪器如下:The analytical characterization instruments used in the present invention are as follows:

1HNMR核磁共振仪:Bruker DMX 300(300MHz),四甲基硅(TMS)为内标,25℃下用于测试配合物配体的结构。 1 HNMR nuclear magnetic resonance apparatus: Bruker DMX 300 (300MHz), tetramethylsilicon (TMS) as the internal standard, used to test the structure of the complex ligand at 25°C.

聚合物的共聚单体含量(衍生自式G所示的烯烃醇的机构单元的含量):采用13CNMR谱测定,在400MHz Bruker Avance 400核磁共振波谱仪上,利用10mm PASEX 13探针,在120℃下以1,2,4-三氯苯溶解聚合物样品,分析测试得到。Comonomer content of the polymer (content of structural units derived from alkene alcohols of formula G): determined using 13 CNMR spectroscopy on a 400 MHz Bruker Avance 400 nuclear magnetic resonance spectrometer using a 10 mm PASEX 13 probe at 120 The polymer sample was dissolved in 1,2,4-trichlorobenzene at ℃, and the result was obtained by analysis and test.

共聚物的分子量及分子量分布PDI(PDI=Mw/Mn):采用PL-GPC220,以三氯苯为溶剂,在150℃下测定(标样:PS,流速:1.0mL/min,柱子:3×Plgel 10um M1×ED-B 300×7.5nm)。The molecular weight and molecular weight distribution PDI of the copolymer (PDI=Mw/Mn): PL-GPC220 was used, and trichlorobenzene was used as solvent, and measured at 150 °C (standard sample: PS, flow rate: 1.0 mL/min, column: 3× Plgel 10um M1×ED-B 300×7.5nm).

活性测量方法:聚合物重量(g)/镍(mol)×2。Activity measurement method: polymer weight (g)/nickel (mol)×2.

为了在实施例中简明清楚的表述配体和配合物,说明如下:In order to express the ligands and complexes concisely and clearly in the examples, the descriptions are as follows:

Figure BDA0002255002120000161
Figure BDA0002255002120000161

二亚胺化合物A1为式V所示的ɑ-二亚胺化合物,其中R1=R3=R4=R6=CH3,R2=R5=R7=R8=R9=R10=R21=R22=H;The diimine compound A1 is an α-diimine compound represented by formula V, wherein R 1 =R 3 =R 4 =R 6 =CH 3 , R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 21 =R 22 =H;

二亚胺化合物A2为式V所示的ɑ-二亚胺化合物,其中R1=R3=R4=R6=i-Pr,R2=R5=R7=R8=R9=R10=R21=R22=H;The diimine compound A2 is an α-diimine compound represented by formula V, wherein R 1 =R 3 =R 4 =R 6 =i-Pr, R 2 =R 5 =R 7 =R 8 =R 9 = R 10 =R 21 =R 22 =H;

二亚胺化合物A3为式V’所示的ɑ-二亚胺化合物,其中R1=R3=R4=R6=Me,R2=R5=R7=R8=R9=R10=R31=R32=H;The diimine compound A3 is an α-diimine compound represented by formula V', wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 31 =R 32 =H;

Figure BDA0002255002120000171
Figure BDA0002255002120000171

配体L1为式VI所示的胺基亚胺化合物,其中R1=R3=R4=R6=CH3,R2=R5=R7=R8=R9=R10=R21=R22=H,R5=CH3Ligand L1 is an aminoimine compound represented by formula VI, wherein R 1 =R 3 =R 4 =R 6 =CH 3 , R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 21 =R 22 =H, R 5 =CH 3 ;

配体L2为式VI所示的胺基亚胺化合物,其中R1=R3=R4=R6=i-Pr,R2=R5=R7=R8=R9=R10=R21=R22=H,R5=CH3Ligand L2 is an aminoimine compound represented by formula VI, wherein R 1 =R 3 =R 4 =R 6 =i-Pr, R 2 =R 5 =R 7 =R 8 =R 9 =R 10 = R 21 =R 22 =H, R 5 =CH 3 ;

配体L3为式VI所示的胺基亚胺化合物,其中R1=R3=R4=R6=CH3,R2=R5=R7=R8=R9=R10=R21=R22=H,R5=Et;Ligand L3 is an aminoimine compound represented by formula VI, wherein R 1 =R 3 =R 4 =R 6 =CH 3 , R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 21 =R 22 =H, R 5 =Et;

配体L4为式VI’所示的胺基亚胺化合物,其中R1=R3=R4=R6=Me,R2=R5=R7=R8=R9=R10=R31=R32=H,R5=CH3Ligand L4 is an aminoimine compound represented by formula VI', wherein R 1 =R 3 =R 4 =R 6 =Me, R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 31 =R 32 =H, R 5 =CH 3 ;

Figure BDA0002255002120000181
Figure BDA0002255002120000181

配合物Ni1为式II所示的配合物,其中R1=R3=R4=R6=CH3,R2=R5=R7=R8=R9=R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;The complex Ni1 is a complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =CH 3 , R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 21 =R 22 =H, R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

配合物Ni2为式II所示的配合物,其中R1=R3=R4=R6=iPr,R2=R5=R7=R8=R9=R10=R21=R22=H;R5=CH3,R11=Et,M=Ni,Y=O,X=Br;The complex Ni2 is a complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =iPr, R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 21 =R 22 =H; R 5 =CH 3 , R 11 =Et, M=Ni, Y=O, X=Br;

配合物Ni3为式II所示的配合物,其中R1=R3=R4=R6=iPr,R2=R5=R7=R8=R9=R10=R21=R22=H;R5=CH3,R11=异丁基,M=Ni,Y=O,X=Br;The complex Ni3 is a complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =iPr, R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 21 =R 22 =H; R 5 =CH 3 , R 11 =isobutyl, M=Ni, Y=O, X=Br;

配合物Ni4为式II所示的配合物,其中R1=R3=R4=R6=CH3,R2=R5=R7=R8=R9=R10=R21=R22=H;R5=Et,R11=Et,M=Ni,Y=O,X=Br;The complex Ni4 is a complex represented by formula II, wherein R 1 =R 3 =R 4 =R 6 =CH 3 , R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 21 =R 22 =H; R 5 =Et, R 11 =Et, M=Ni, Y=O, X=Br;

配合物Ni5为式(II’)所示的配合物,其中R1=R3=R4=R6=CH3,R2=R5=R7=R8=R9=R10=R31=R32=H;R5=Me,R11=Et,M=Ni,Y=O,X=Br。The complex Ni5 is a complex represented by formula (II'), wherein R 1 =R 3 =R 4 =R 6 =CH 3 , R 2 =R 5 =R 7 =R 8 =R 9 =R 10 =R 31 = R32 =H ; R5=Me, R11 =Et, M=Ni, Y=O, X=Br.

实施例1Example 1

1)配体L1制备:1) Preparation of ligand L1:

ɑ-二亚胺化合物A1 3.52g(8mmol),依次加入30ml甲苯,1M三甲基铝(16ml,16mmol),回流反应8小时,用氢氧化钠/冰水终止反应,乙酸乙酯萃取,合并有机相,无水硫酸镁干燥,产物经石油醚/乙酸乙酯柱层色谱分离,得到无色晶体配体L1,产率为85.2%。1HNMRδ(ppm)7.23-6.88(m,14H),4.84(s,1H),4.73(s,1H),3.85(s,1H,NH),2.02(s,3H,CH3),1.87(s,6H,CH3),1.75(s,6H,CH3).ɑ-diimine compound A1 3.52g (8mmol), successively added 30ml toluene, 1M trimethylaluminum (16ml, 16mmol), refluxed for 8 hours, terminated the reaction with sodium hydroxide/ice water, extracted with ethyl acetate, combined The organic phase was dried over anhydrous magnesium sulfate, and the product was separated by petroleum ether/ethyl acetate column chromatography to obtain the colorless crystal ligand L1 with a yield of 85.2%. 1 HNMRδ(ppm) 7.23-6.88(m, 14H), 4.84(s, 1H), 4.73(s, 1H), 3.85(s, 1H, NH), 2.02(s, 3H, CH 3 ), 1.87(s , 6H, CH 3 ), 1.75(s, 6H, CH 3 ).

2)配合物Ni1的制备:将10ml(DME)NiBr2(277mg,0.9mmol)的乙醇溶液滴加到10ml配体L1(274mg,0.6mmol)的二氯甲烷溶液中,室温搅拌6小时,析出沉淀,过滤用乙醚洗涤后干燥得到红色粉末固体,产率为74%。元素分析(C70H74Br6N4Ni3O2):C,50.68;H,4.50;N,3.38;实验值(%):C,50.53;H,4.73;N,3.21。2) Preparation of complex Ni1: 10 ml of (DME) NiBr 2 (277 mg, 0.9 mmol) in ethanol was added dropwise to a dichloromethane solution of 10 ml of ligand L1 (274 mg, 0.6 mmol), stirred at room temperature for 6 hours, and precipitated. The precipitate was filtered, washed with ether and dried to give a red powder solid in 74% yield. Elemental analysis (C 70 H 74 Br 6 N 4 Ni 3 O 2 ): C, 50.68; H, 4.50; N, 3.38; found (%): C, 50.53; H, 4.73; N, 3.21.

3)将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.3mg(5μmol)配合物Ni1,15mmol(2.5mL)2-甲基-2-羟基-7-辛烯,15mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。3) The 1L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130°C for 6h, vacuumized while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 15 mmol (2.5 mL) of 2-methyl-2-hydroxy-7-octene, 15 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例2Example 2

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.3mg(5μmol)配合物Ni1,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例3Example 3

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.3mg(5μmol)配合物Ni1,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在60℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 60° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例4Example 4

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.3mg(5μmol)配合物Ni1,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),0.5mL二乙基锌(1mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 0.5 mL of diethyl zinc (1 mol/L hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例5Example 5

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.3mg(5μmol)配合物Ni1,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),1.0mL二乙基锌(1mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 1.0 mL of diethylzinc (1 mol/L hexane solution), 6.5 mL MAO (1.53 mol/L toluene solution), at 30 °C, maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例6Example 6

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.3mg(5μmol)配合物Ni1,50mmol(8.5mL)2-甲基-2-羟基-7-辛烯,50mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 50 mmol (8.5 mL) of 2-methyl-2-hydroxy-7-octene, 50 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例7Example 7

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.3mg(5μmol)配合物Ni1,100mmol(17.0mL)2-甲基-2-羟基-7-辛烯,100mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 100 mmol (17.0 mL) of 2-methyl-2-hydroxy-7-octene, 100 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例8Example 8

1)配体L2的制备:1) Preparation of ligand L2:

ɑ-二亚胺化合物A2 4.42g(8mmol),依次加入30ml甲苯,1M三甲基铝(16ml,16mmol),回流反应8小时,用氢氧化钠/冰水终止反应,乙酸乙酯萃取,合并有机相,无水硫酸镁干燥,产物经石油醚/乙酸乙酯柱层色谱分离,得到无色晶体配体L2,产率为76.2%。1HNMRδ(ppm)7.21-6.95(m,14H),4.96(s,1H),4.87(s,1H),3.85(s,1H,NH),2.51(m,4H,CH(CH3)2),2.02(s,3H,CH3),1.18(d,3H,CH3),1.11(d,3H,CH3),1.05(d,6H,CH3),0.98(d,6H,CH3),0.60(d,6H,CH3).ɑ-diimine compound A2 4.42g (8mmol), successively added 30ml toluene, 1M trimethylaluminum (16ml, 16mmol), refluxed for 8 hours, terminated the reaction with sodium hydroxide/ice water, extracted with ethyl acetate, combined The organic phase was dried over anhydrous magnesium sulfate, and the product was separated by petroleum ether/ethyl acetate column chromatography to obtain the colorless crystal ligand L2 with a yield of 76.2%. 1 HNMRδ(ppm) 7.21-6.95(m, 14H), 4.96(s, 1H), 4.87(s, 1H), 3.85(s, 1H, NH), 2.51(m, 4H, CH(CH 3 ) 2 ) , 2.02(s, 3H, CH 3 ), 1.18(d, 3H, CH 3 ), 1.11(d, 3H, CH 3 ), 1.05(d, 6H, CH 3 ), 0.98(d, 6H, CH 3 ) ,0.60(d,6H,CH 3 ).

2)配合物Ni2的制备:将10ml(DME)NiBr2(277mg,0.9mmol)的乙醇溶液滴加到10ml配体L2(341mg,0.6mmol)的二氯甲烷溶液中,室温搅拌6小时,析出沉淀,过滤用乙醚洗涤后干燥得到红色粉末固体,产率为76%。元素分析(C86H106Br6N4Ni3O2):C,54.85;H,5.67;N,2.97;实验值(%):C,54.61;H,5.73;N,3.14。2) Preparation of complex Ni2: 10ml of (DME) NiBr2 (277mg, 0.9mmol) in ethanol was added dropwise to 10ml of Ligand L2 (341mg, 0.6mmol) in dichloromethane solution, stirred at room temperature for 6 hours, and precipitated. The precipitate was filtered, washed with ether and dried to give a red powder solid in 76% yield. Elemental analysis (C 86 H 106 Br 6 N 4 Ni 3 O 2 ): C, 54.85; H, 5.67; N, 2.97; found (%): C, 54.61; H, 5.73; N, 3.14.

3)将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入9.4mg(5μmol)配合物Ni2,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。3) The 1L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130°C for 6h, vacuumized while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 9.4 mg (5 μmol) of complex Ni 2 , 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例9Example 9

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入9.4mg(5μmol)配合物Ni2,30mmol(8.5mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在60℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 9.4 mg (5 μmol) of complex Ni 2, 30 mmol (8.5 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 60° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例10Example 10

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入9.4mg(5μmol)配合物Ni2,30mmol(4.1mL)3-甲基-5-己烯-3-醇,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应60min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 9.4 mg (5 μmol) of complex Ni 2 , 30 mmol (4.1 mL) of 3-methyl-5-hexen-3-ol, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 60 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例11Example 11

将含有277mg(0.9mmol)(DME)NiBr2的2-甲基-1-丙醇溶液(10mL)缓慢滴加到含有341mg(0.6mmol)配体L2的二氯甲烷溶液(10mL)中。溶液的颜色立刻变为深红色,并有大量沉淀生成。室温下搅拌6h,加入无水乙醚沉淀。过滤留得滤饼,用无水乙醚洗涤滤饼,真空干燥后得到棕红色粉末状固体Ni3。产率为84.0%。FT-IR(KBr disc,cm-1)2969,1677,1628,1462,1342,1109,794,760。元素分析(C90H114Br6N4Ni3O2):C,55.74;H,5.92;N,2.89;实验值(%):C,56.08;H,6.12;N,3.08。A solution of 277 mg (0.9 mmol) of (DME)NiBr2 in 2 -methyl-1-propanol (10 mL) was slowly added dropwise to a solution of 341 mg (0.6 mmol) of ligand L2 in dichloromethane (10 mL). The color of the solution immediately changed to dark red, and a large amount of precipitate formed. The mixture was stirred at room temperature for 6 h, and then precipitated by adding anhydrous ether. The filter cake was left after filtration, washed with anhydrous ether, and dried in vacuo to obtain a brown-red powdery solid Ni3. The yield was 84.0%. FT-IR (KBr disc, cm -1 ) 2969, 1677, 1628, 1462, 1342, 1109, 794, 760. Elemental analysis (C 90 H 114 Br 6 N 4 Ni 3 O 2 ): C, 55.74; H, 5.92; N, 2.89; found (%): C, 56.08; H, 6.12; N, 3.08.

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入9.7mg(5μmol)配合物Ni3,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应60min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 9.7 mg (5 μmol) of complex Ni 3 , 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 60 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例12Example 12

1)配体L3的制备:ɑ-二亚胺化合物A1 3.52g(8mmol),依次加入30ml乙醚,2M二乙基锌(4ml,8mmol)常温搅拌3小时,用冰水终止反应,乙酸乙酯萃取,合并有机相,无水硫酸镁干燥,产物经石油醚/乙酸乙酯柱层色谱分离,得到无色晶体配体L3,产率为50.1%。1HNMRδ(ppm)7.22-6.86(m,14H),4.82(s,1H),4.73(s,1H),3.85(s,1H,NH),2.04(m,2H,CH2CH3),1.89(s,6H,CH3),1.74(s,6H,CH3),0.89(t,3H,CH3).1) preparation of ligand L3: ɑ-diimine compound A1 3.52g (8mmol), add 30ml ether successively, 2M diethylzinc (4ml, 8mmol) stirs at room temperature for 3 hours, terminates the reaction with ice water, ethyl acetate After extraction, the organic phases were combined, dried over anhydrous magnesium sulfate, and the product was separated by petroleum ether/ethyl acetate column chromatography to obtain the colorless crystalline ligand L3 in a yield of 50.1%. 1 HNMRδ(ppm) 7.22-6.86(m, 14H), 4.82(s, 1H), 4.73(s, 1H), 3.85(s, 1H, NH), 2.04(m, 2H, CH 2 CH 3 ), 1.89 (s, 6H, CH 3 ), 1.74 (s, 6H, CH 3 ), 0.89 (t, 3H, CH 3 ).

2)配合物Ni4的制备:将10ml(DME)NiBr2(277mg,0.9mmol)的乙醇溶液滴加到10ml配体L3(282mg,0.6mmol)的二氯甲烷溶液中,室温搅拌6小时,析出沉淀,过滤用乙醚洗涤后干燥得到红色粉末固体,产率为73%。元素分析(C72H78Br6N4Ni3O2):C,51.26;H,4.66;N,3.32;实验值(%):C,51.39;H,4.93;N,3.24。2) Preparation of complex Ni4: 10 ml (DME) NiBr 2 (277 mg, 0.9 mmol) in ethanol was added dropwise to 10 ml of ligand L3 (282 mg, 0.6 mmol) in dichloromethane solution, stirred at room temperature for 6 hours, and precipitated. The precipitate was filtered, washed with ether and dried to give a red powder solid in 73% yield. Elemental analysis (C 72 H 78 Br 6 N 4 Ni 3 O 2 ): C, 51.26; H, 4.66; N, 3.32; found (%): C, 51.39; H, 4.93; N, 3.24.

3)将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.4mg(5μmol)配合物Ni4,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。3) The 1L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130°C for 6h, vacuumized while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.4 mg (5 μmol) of complex Ni4, 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例13Example 13

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.4mg(5μmol)配合物Ni4,30mmol(4.5mL)4-甲基-1-庚烯-4-醇,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and simultaneously add 8.4 mg (5 μmol) of complex Ni4, 30 mmol (4.5 mL) of 4-methyl-1-hepten-4-ol, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例14Example 14

Figure BDA0002255002120000231
Figure BDA0002255002120000231

1)配体L4的制备:ɑ-二亚胺化合物A3 4.32g(8mmol),依次加入30ml甲苯,1M三甲基铝(16ml,16mmol)常温搅拌3小时,用冰水终止反应,乙酸乙酯萃取,合并有机相,无水硫酸镁干燥,产物经石油醚/乙酸乙酯柱层色谱分离,得到无色晶体配体L4,产率为72.1%。1HNMRδ(ppm)7.68-7.54(m,8H),7.37(m,4H),7.11-7.04(m,6H),5.16(s,1H),5.08(s,1H),4.05(s,1H,NH),1.94(s,3H,CH3),1.89(s,6H,CH3),1.73(s,6H,CH3).1) preparation of ligand L4: ɑ-diimine compound A3 4.32g (8mmol), add 30ml toluene successively, 1M trimethylaluminum (16ml, 16mmol) stirs at room temperature for 3 hours, terminates the reaction with ice water, ethyl acetate After extraction, the organic phases were combined, dried over anhydrous magnesium sulfate, and the product was separated by petroleum ether/ethyl acetate column chromatography to obtain the colorless crystal ligand L4 with a yield of 72.1%. 1 HNMRδ(ppm) 7.68-7.54(m, 8H), 7.37(m, 4H), 7.11-7.04(m, 6H), 5.16(s, 1H), 5.08(s, 1H), 4.05(s, 1H, NH), 1.94 (s, 3H, CH 3 ), 1.89 (s, 6H, CH 3 ), 1.73 (s, 6H, CH 3 ).

2)配合物Ni5的制备:将10ml(DME)NiBr2(277mg,0.9mmol)的乙醇溶液滴加到10ml配体L4(334mg,0.6mmol)的二氯甲烷溶液中,室温搅拌6小时,析出沉淀,过滤用乙醚洗涤后干燥得到红色粉末固体,产率为72%。元素分析(C86H82Br6N4Ni3O2):C,55.56;H,4.45;N,3.01;实验值(%):C,55.74;H,4.73;N,3.14。2) Preparation of complex Ni5: 10 ml of (DME) NiBr 2 (277 mg, 0.9 mmol) in ethanol was added dropwise to a solution of 10 ml of ligand L4 (334 mg, 0.6 mmol) in dichloromethane, stirred at room temperature for 6 hours, and precipitated. The precipitate was filtered, washed with ether and dried to give a red powder solid in 72% yield. Elemental analysis (C 86 H 82 Br 6 N 4 Ni 3 O 2 ): C, 55.56; H, 4.45; N, 3.01; found (%): C, 55.74; H, 4.73; N, 3.14.

3)10atm乙烯聚合:将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6hrs,趁热抽真空并用N2气置换3次。加入9.3mg(5μmol)配合物Ni5然后再抽真空并用乙烯置换3次。注入500ml的己烷,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),再加入6.5ml甲基铝氧烷(MAO)(1.53mol/l的甲苯溶液)。在60℃下,保持10atm的乙烯压力,剧烈搅拌反应30min。用10wt%盐酸酸化的乙醇溶液中和,得到聚乙烯。3) 10 atm ethylene polymerization: a 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130° C. for 6 hrs, evacuated while hot, and replaced with N gas 3 times. 9.3 mg (5 [mu]mol) of complex Ni5 were added and then evacuated and replaced 3 times with ethylene. Inject 500 ml of hexane, 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L hexane solution), and then add 6.5 ml of methylaluminoxane (MAO ) (1.53 mol/l in toluene). At 60 °C, maintaining the ethylene pressure of 10 atm, the reaction was vigorously stirred for 30 min. Neutralize with 10 wt% hydrochloric acid acidified ethanol solution to obtain polyethylene.

实施例15Example 15

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.3mg(5μmol)配合物Ni1,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),加入15mL N,N-二甲基苯铵四(五氟苯基)硼酸盐的甲苯溶液(1mmol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L of hexane solution), add 15 mL of N,N-dimethylanilinium tetrakis (pentafluorophenyl) borate toluene solution (1 mmol/L toluene solution), at 30 ° C, keep the ethylene pressure of 10 atm, and stir the reaction for 30 min . Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例16Example 16

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的己烷,同时加入8.3mg(5μmol)配合物Ni1,30mmol(6.0mL)10-十一烯-1-醇,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of hexane into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 30 mmol (6.0 mL) of 10-undec-1-ol, 30 mL of AlEt 3 (1.0 mol/L hexane solution), 6.5 mL MAO (1.53 mol/L toluene solution), at 30 °C, maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

实施例17Example 17

将装有机械搅拌的1L不锈钢聚合釜在130℃连续干燥6h,趁热抽真空并用N2气置换3次。向聚合体系注入500mL的甲苯,同时加入8.3mg(5μmol)配合物Ni1,30mmol(5.1mL)2-甲基-2-羟基-7-辛烯,30mL AlEt3(1.0mol/L的己烷溶液),6.5mL MAO(1.53mol/L的甲苯溶液),在30℃下,保持10atm的乙烯压力,搅拌反应30min。最后用10wt%盐酸酸化的乙醇溶液中和,得到聚合物。聚合活性以及聚合物的性能参数如表1所示。A 1 L stainless steel polymerization kettle equipped with mechanical stirring was continuously dried at 130 °C for 6 h, evacuated while hot, and replaced with N 2 gas for 3 times. Inject 500 mL of toluene into the polymerization system, and at the same time add 8.3 mg (5 μmol) of complex Ni1, 30 mmol (5.1 mL) of 2-methyl-2-hydroxy-7-octene, 30 mL of AlEt 3 (1.0 mol/L hexane solution) ), 6.5 mL of MAO (1.53 mol/L toluene solution), at 30° C., maintaining an ethylene pressure of 10 atm, and stirring the reaction for 30 min. Finally, it was neutralized with an ethanol solution acidified with 10 wt% hydrochloric acid to obtain a polymer. The polymerization activity and the performance parameters of the polymers are shown in Table 1.

表1Table 1

Figure BDA0002255002120000241
Figure BDA0002255002120000241

Figure BDA0002255002120000251
Figure BDA0002255002120000251

由表1可以看出,本发明的催化剂催化乙烯同烯醇共聚时,表现出较高的聚合活性,且所得聚合物有较高的分子量。本发明催化剂的共聚活性最高可达5.27×105g·mol-1(Ni)·h-1。聚合物的分子量可根据链转移剂的加入在较宽范围内进行调控。另外,通过调控聚合条件,可制得颗粒形态良好的共聚产物。As can be seen from Table 1, when the catalyst of the present invention catalyzes the copolymerization of ethylene with enol, it exhibits higher polymerization activity, and the obtained polymer has higher molecular weight. The copolymerization activity of the catalyst of the invention can reach up to 5.27×105g·mol -1 (Ni)·h -1 . The molecular weight of the polymer can be adjusted within a wide range depending on the addition of the chain transfer agent. In addition, by adjusting the polymerization conditions, a copolymer product with good particle morphology can be obtained.

应当注意的是,以上所述的实施例仅用于解释本发明,并不对本发明构成任何限制。通过参照典型实施例对本发明进行了描述,但应当理解为其中所用的词语为描述性和解释性词汇,而不是限定性的词汇。可以按规定在本发明权利要求的范围内对本发明作出修改,以及在不背离本发明的范围和精神内对本发明进行修订。尽管其中描述的本发明涉及特定的方法、材料和实施例,但是并不意味着请本发明限于其中公开的特定例,相反,本发明可以扩展至其它所有具有相同功能的方法和应用。It should be noted that the above-mentioned embodiments are only used to explain the present invention, and do not constitute any limitation to the present invention. The present invention has been described with reference to exemplary embodiments, but it is to be understood that the words used therein are words of description and explanation, rather than words of limitation. The present invention may be modified within the scope of the claims of the present invention as specified, and may be modified without departing from the scope and spirit of the present invention. Although the invention described herein refers to specific methods, materials and embodiments, it is not intended to be limited to the specific examples disclosed therein, but rather, the invention extends to all other methods and applications having the same function.

Claims (42)

1. A process for preparing an olefin-olefin alcohol copolymer comprising polymerizing an olefin and an olefin alcohol in the presence of a catalyst and optionally a chain transfer agent to produce the olefin-olefin alcohol copolymer,
the catalyst comprises a main catalyst and an optional cocatalyst, wherein the main catalyst comprises an amino imine complex shown as a formula I:
Figure FDA0003501750620000011
in the formula I, R1And R2Is a group of formula A:
in the formula A, R1-R5The same or different, each is independently selected from hydrogen, halogen, hydroxyl, C1-C20 alkyl with or without substituent, C2-C20 alkenyl with or without substituent, C2-C20 alkynyl with or without substituent, C1-C20 alkoxy with or without substituent, substituted or unsubstituted C2-C20 alkenyloxy, substituted or unsubstituted C2-C20 alkynyloxy, substituted or unsubstituted C6-C20 aryl, substituted or unsubstituted C7-C20 aralkyl, substituted or unsubstituted C7-C20 alkaryl, substituted or unsubstituted C6-C20 aryloxy, substituted or unsubstituted C7-C20 aralkyloxy, and substituted or unsubstituted C7-C20 alkaryloxy; r1-R5Optionally forming a ring with each other;
in the formula I, R21-R24The same or different, each is independently selected from hydrogen, halogen, hydroxyl, C1-C20 alkyl containing substituent or not containing substituent, and C1-C20 alkoxy containing substituent or not containing substituent; r21-R24Optionally forming a ring with each other; r5Selected from hydrogen and substituted or unsubstituted C1-C20 hydrocarbyl; r is11Selected from C1-C20 substituted or unsubstituted hydrocarbon groups; y is selected from non-metal atoms of group VIA; m is a group VIII metal; x is selected from halogen, C1-C10 alkyl with or without substituent and C1-C10 alkoxy with or without substituent.
2. The method of claim 1, wherein R is21And R22Form a benzene ring which may be substitutedHas a substituent.
3. The method of claim 1, wherein R in formula A1-R5The same or different, each is independently selected from hydrogen, halogen, hydroxyl, C1-C10 alkyl with or without substituent, C2-C10 alkenyl with or without substituent, C2-C10 alkynyl with or without substituent, C1-C10 alkoxy with or without substituent, substituted or unsubstituted C2-C10 alkenyloxy, substituted or unsubstituted C2-C10 alkynyloxy, substituted or unsubstituted C6-C15 aryl, substituted or unsubstituted C7-C15 aralkyl, substituted or unsubstituted C7-C15 alkaryl, substituted or unsubstituted C6-C15 aryloxy, substituted or unsubstituted C7-C15 aralkyloxy and substituted or unsubstituted C7-C15 alkaryloxy.
4. The method of claim 3, wherein R is1-R5The same or different, each is independently selected from hydrogen, halogen, hydroxyl, C1-C6 alkyl with or without substituent, C2-C6 alkenyl with or without substituent, C2-C6 alkynyl with or without substituent, C1-C6 alkoxy with or without substituent, substituted or unsubstituted C2-C6 alkenyloxy, substituted or unsubstituted C2-C6 alkynyloxy, substituted or unsubstituted C6-C10 aryl, substituted or unsubstituted C7-C10 aralkyl, substituted or unsubstituted C7-C10 alkaryl, substituted or unsubstituted C6-C10 aryloxy, substituted or unsubstituted C7-C10 aralkyloxy and substituted or unsubstituted C7-C10 alkaryloxy.
5. The method of claim 1, wherein M is selected from the group consisting of nickel and palladium; y is selected from O and S; x is selected from halogen, C1-C10 alkyl with or without substituent, and C1-C10 alkoxy with or without substituent;
R11is selected from self-contained fetchingA substituted or unsubstituted C1-C20 alkyl group;
R5is selected from C1-C20 alkyl with or without substituent, C6-C20 aryl with or without substituent, C7-C20 aralkyl with or without substituent and C7-C20 alkaryl with or without substituent.
6. The method of claim 5, wherein X is selected from the group consisting of halogen, substituted or unsubstituted C1-C6 alkyl, and substituted or unsubstituted C1-C6 alkoxy.
7. The method of claim 5, wherein R is11Is C1-C10 alkyl with or without substituent.
8. The method of claim 7, wherein R is11Is C1-C6 alkyl with or without substituent.
9. The method of claim 5, wherein R is5Is selected from C1-C10 alkyl with or without substituent, C6-C10 aryl with or without substituent, C7-C15 aralkyl with or without substituent and C7-C15 alkaryl with or without substituent.
10. The method of claim 9, wherein R is5Is selected from C1-C6 alkyl containing substituent or not containing substituent.
11. The method of claim 10, wherein R is5Selected from methyl, ethyl, propyl or butyl.
12. The method of claim 1, wherein R is21-R24The same or different, each is independently selected from hydrogen, halogen, hydroxyl, C1-C20 alkyl with or without substituent, and with or without substituentC2-C20 alkenyl, substituted or unsubstituted C2-C20 alkynyl, substituted or unsubstituted C1-C20 alkoxy, substituted or unsubstituted C2-C20 alkenyloxy, substituted or unsubstituted C2-C20 alkynyloxy, substituted or unsubstituted C6-C20 aryl, substituted or unsubstituted C7-C20 aralkyl, substituted or unsubstituted C7-C20 alkaryl, substituted or unsubstituted C6-C20 aryloxy, substituted or unsubstituted C7-C20 aralkyloxy, and substituted or unsubstituted C7-C20 alkaryloxy; r21-R24Optionally forming a ring with each other.
13. The method of claim 12, wherein R is21-R24The same or different, each is independently selected from hydrogen, halogen, hydroxyl, C1-C10 alkyl with or without substituent, C2-C10 alkenyl with or without substituent, C2-C10 alkynyl with or without substituent, C1-C10 alkoxy with or without substituent, substituted or unsubstituted C2-C10 alkenyloxy, substituted or unsubstituted C2-C10 alkynyloxy, substituted or unsubstituted C6-C15 aryl, substituted or unsubstituted C7-C15 aralkyl, substituted or unsubstituted C7-C15 alkaryl, substituted or unsubstituted C6-C15 aryloxy, substituted or unsubstituted C7-C15 aralkyloxy and substituted or unsubstituted C7-C15 alkaryloxy.
14. The method of claim 13, wherein R is21-R24The same or different, are each independently selected from hydrogen, C1-C10 alkyl, halogenated C1-C10 alkyl, C1-C10 alkoxy, halogenated C1-C10 alkoxy, and halogen.
15. The method of claim 14, wherein R is21-R24The same or different, are each independently selected from hydrogen, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkoxy, and halogen.
16. A method as claimed in any one of claims 1 to 13 wherein said substituents are selected from halogen, hydroxy, C1-C10 alkyl, halogenated C1-C10 alkyl, C1-C10 alkoxy and halogenated C1-C10 alkoxy.
17. The method of claim 16, wherein the substituents are selected from the group consisting of halogen, hydroxy, C1-C6 alkyl, halogenated C1-C6 alkyl, C1-C6 alkoxy, and halogenated C1-C6 alkoxy.
18. The method of claim 17, wherein the C1-C6 alkyl is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, and isobutyl, n-pentyl, isopentyl, n-hexyl, isohexyl, 3, 3-dimethylbutyl.
19. The method of claim 18, wherein the C1-C6 alkoxy is selected from methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy and isobutoxy, n-pentoxy, isopentoxy, n-hexoxy, isohexoxy, 3, 3-dimethylbutoxy.
20. The method of claim 16, wherein the halogen is selected from the group consisting of fluorine, chlorine, bromine, and iodine.
21. A process according to any one of claims 1 to 15, wherein the aminoimine complex has the substructure according to formula IA:
Figure FDA0003501750620000041
wherein R is31-R34And R in the formula I21-R24Have the same definition.
22. According to claim 21The method is characterized in that R33And R34Is hydrogen.
23. The process of any one of claims 1 to 15, wherein the procatalyst comprises one or more of the following complexes:
Figure FDA0003501750620000051
1) a complex of formula II wherein R1=R3=R4=R6Is isopropyl, R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
2) A complex of formula II wherein R1=R3=R4=R6=Et,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
3) A complex of formula II wherein R1=R3=R4=R6=Me,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
4) A complex of formula II wherein R1-R6=Me,R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
5) A complex of formula II wherein R1=R3=R4=R6=Br,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
6) A complex of formula II wherein R1=R3=R4=R6=Cl,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
7) A complex of formula II wherein R1=R3=R4=R6=F,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
8) A complex of formula II wherein R1=R3=R4=R6Is isopropyl, R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;
9) A complex of formula II wherein R1=R3=R4=R6=Et,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;
10) A complex of formula II wherein R1=R3=R4=R6=Me,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;
11) A complex of formula II wherein R1-R6=Me,R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;
12) A complex of formula II wherein R1=R3=R4=R6=Br,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;
13) A complex of formula II wherein R1=R3=R4=R6=Cl,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;
14) A complex of formula II wherein R1=R3=R4=R6=F,R2=R5=R7-R10=R21=R22=H,R5=R11=Et,M=Ni,Y=O,X=Br;
15) A complex of formula II wherein R1=R3=R4=R6Is isopropyl, R2=R5=R7-R10=R21=R22=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
16) a complex of formula II wherein R1=R3=R4=R6=Et,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
17) a complex of formula II wherein R1=R3=R4=R6=Me,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
18) a complex of formula II wherein R1-R6=Me,R7-R10=R21=R22=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
19) a complex of formula II wherein R1=R3=R4=R6=Br,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
20) a complex of formula II wherein R1=R3=R4=R6=Cl,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
21) a complex of formula II wherein R1=R3=R4=R6=F,R2=R5=R7-R10=R21=R22=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
22) a complex of formula II wherein R1=R3=R4=R6Is isopropyl, R2=R5=R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
23) A complex of formula II wherein R1=R3=R4=R6=Et,R2=R5=R7-R10=R22=H,R21Is tert-butyl, R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
24) A complex of formula II wherein R1=R3=R4=R6=Me,R2=R5=R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
25) A complex of formula II wherein R1-R6=Me,R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
26) A complex of formula II wherein R1=R3=R4=R6=Br,R2=R5=R7-R10=R22=H,R21Is tert-butyl, R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
27) A complex of formula II wherein R1=R3=R4=R6=Cl,R2=R5=R7-R10=R22=H,R21Is tert-butyl, R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
28) A complex of formula II wherein R1=R3=R4=R6=F,R2=R5=R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
29) A complex of formula II wherein R1=R3=R4=R6Is ═ isopropyl, R2=R5=R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
30) a complex of formula II wherein R1=R3=R4=R6=Et,R2=R5=R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
31) a complex of formula II wherein R1=R3=R4=R6=Me,R2=R5=R7-R10=R22=H,R21Is tert-butyl, R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
32) a complex of formula II wherein R1-R6=Me,R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
33) a complex of formula II wherein R1=R3=R4=R6=Br,R2=R5=R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
34) a complex of formula II wherein R1=R3=R4=R6=Cl,R2=R5=R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
35) a complex of formula II wherein R1=R3=R4=R6=F,R2=R5=R7-R10=R22=H,R21Tert-butyl radical, R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
Figure FDA0003501750620000081
29) a complex of formula (II') wherein R1=R3=R4=R6Is isopropyl, R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
30) A complex of formula (II') wherein R1=R3=R4=R6=Et,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
31) A complex of formula (II') wherein R1=R3=R4=R6=Me,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
32) A complex of formula (II') wherein R1-R6=Me,R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
33) A complex of formula (II') wherein R1=R3=R4=R6=Br,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
34) A complex of formula (II') wherein R1=R3=R4=R6=Cl,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
35) A complex of formula (II') wherein R1=R3=R4=R6=F,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11=Et,M=Ni,Y=O,X=Br;
36) A complex of formula (II') wherein R1=R3=R4=R6Is isopropyl, R2=R5=R7-R10=R31=R32=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
37) a complex of formula (II') wherein R1=R3=R4=R6=Et,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
38) a complex of formula (II') wherein R1=R3=R4=R6=Me,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
39) a complex of formula (II') wherein R1-R6=Me,R7-R10=R31=R32=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
40) a complex of formula (II') wherein R1=R3=R4=R6=Br,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
41) a complex of formula (II') wherein R1=R3=R4=R6=Cl,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
42) a complex of formula (II') wherein R1=R3=R4=R6=F,R2=R5=R7-R10=R31=R32=H,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
43) a complex of formula (II') wherein R1=R3=R4=R6Is isopropyl, R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;
44) A complex of formula (II') wherein R1=R3=R4=R6=Et,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;
45) A complex of formula (II') wherein R1=R3=R4=R6=Me,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;
46) A complex of formula (II') wherein R1-R6=Me,R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;
47) A complex of formula (II') wherein R1=R3=R4=R6=Br,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;
48) A complex of formula (II') wherein R1=R3=R4=R6=Cl,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;
49 of the formula (II'), wherein R1=R3=R4=R6=F,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;
50) A complex of formula (II') wherein R1=R3=R4=R6Is isopropyl group,R2=R5=R7-R10=H,R31=R32=R11=Et,R5=CH3,M=Ni,Y=O,X=Br;
51) A complex of formula (II') wherein R1=R3=R4=R6=Et,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
52) a complex of formula (II') wherein R1=R3=R4=R6=Me,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
53) a complex of formula (II') wherein R1-R6=Me,R7-R10=H,R31=R32=Et,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
54) a complex of formula (II') wherein R1=R3=R4=R6=Br,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
55) a complex of formula (II') wherein R1=R3=R4=R6=Cl,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11Isobutyl, M ═ Ni, Y ═ O, X ═ Br;
56) a complex of formula (II') wherein R1=R3=R4=R6=F,R2=R5=R7-R10=H,R31=R32=Et,R5=CH3,R11I.e., isobutyl, M ═ Ni, Y ═ O, and X ═ Br.
24. The method of any one of claims 1-15, wherein the olefin comprises an olefin having 2-16 carbon atoms.
25. The method of claim 24, wherein the olefin comprises ethylene or an alpha-olefin having 3 to 16 carbon atoms.
26. The process of any one of claims 1 to 15, wherein the alkene alcohol is selected from one or more alkene alcohols of formula G:
Figure FDA0003501750620000101
in the formula G, L1-L3Each independently selected from H and C with or without substituent1-C30Alkyl radical, L4Is C having a pendant group1-C30An alkylene group.
27. The method of claim 26, wherein the copolymer has a content of structural units derived from the alkene alcohol of formula G in the range of 0.4 to 10.0 mol%.
28. The method of claim 26, wherein L is1And L2Is H, L3Is H or C1-C30Alkyl radical, L4Is C having a pendant group1-C30An alkylene group.
29. The method of claim 26, wherein L is1And L2Is H, L3Is H or C1-C20Alkyl radical, L4Is C having a pendant group1-C20An alkylene group.
30. The method of claim 26, wherein L is1And L2Is H, L3Is H or C1-C10Alkyl radical, L4Is C having a pendant group1-C10An alkylene group.
31. The method of claim 26, wherein L is1And L2Is H, L3Is H or C1-C10Alkyl radical, L4Is C having a pendant group1-C6An alkylene group.
32. The method of claim 26, wherein L is1-L3Wherein said substituents are selected from halogen, C1-C10Alkyl radical, C1-C10Alkoxy radical, C6-C10One or more of aryl, cyano and hydroxyl;
L4wherein the side group is selected from halogen, C6-C20Aryl radical, C1-C20Alkyl and C1-C20One or more of alkoxy, said C6-C20Aryl radical, C1-C20Alkyl and C1-C20Alkoxy is optionally substituted with a substituent.
33. The method of claim 32, wherein L is1-L3Wherein said substituent is selected from C1-C6Alkyl, halogen and C1-C6One or more of alkoxy groups.
34. The method of claim 33, wherein L is4Wherein said substituents are selected from halogen, C1-C10Alkyl radical, C1-C10Alkoxy radical, C6-C10One or more of aryl and hydroxyl.
35. A process according to any one of claims 1 to 15 characterised in that the cocatalyst is selected from organoaluminium compounds and/or organoboron compounds; the organic aluminum compound is selected from one or more of alkyl aluminoxane, alkyl aluminum and alkyl aluminum halide; the organoboron compound is selected from an aryl boron and/or a borate; the chain transfer agent is selected from one or more of alkyl aluminum, alkyl magnesium and alkyl zinc.
36. The method as claimed in claim 35, wherein when the cocatalyst is an organoaluminum compound, the molar ratio of aluminum in the cocatalyst to M in the aminoimine-based complex is 10 to 1071, preparing a catalyst; when the cocatalyst is an organic boron compound, the molar ratio of boron in the cocatalyst to M in the amino imine complex is 0.1-1000: 1; the molar ratio of the chain transfer agent to M in the amino imine complex is 0.1-5000: 1.
37. The process of claim 36, wherein when the cocatalyst is an organoaluminum compound, the molar ratio of aluminum in the cocatalyst to M in the aminoimine-based complex is 10-100000: 1.
38. The method as recited in claim 36, wherein when the cocatalyst is an organoaluminum compound, the molar ratio of aluminum in the cocatalyst to M in the aminoimine-based complex is 100-10000: 1.
39. The method of claim 36, wherein when the cocatalyst is an organoboron compound, the molar ratio of boron in the cocatalyst to M in the aminoimine complex is from 0.1 to 500: 1.
40. The method of claim 36, wherein the molar ratio of the chain transfer agent to M in the aminoimine complex is 1.0 to 1000: 1.
41. An olefin-olefin alcohol copolymer prepared according to the process of any one of claims 1 to 40, which is spherical and/or spheroidal, and/or which has a particle size of from 0.1 to 50 mm.
42. Use of an olefin-olefin alcohol copolymer prepared according to the process of any one of claims 1 to 40 or the olefin-olefin alcohol copolymer of claim 41 as a polyolefin material.
CN201911049604.4A 2019-10-31 2019-10-31 A kind of preparation method of olefin-olefin alcohol copolymer Active CN112745428B (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN201911049604.4A CN112745428B (en) 2019-10-31 2019-10-31 A kind of preparation method of olefin-olefin alcohol copolymer
JP2022525809A JP2023500504A (en) 2019-10-31 2020-10-30 Method for preparing olefin-polar monomer copolymers
PCT/CN2020/125433 WO2021083358A1 (en) 2019-10-31 2020-10-30 Method for preparing olefin-polar monomer copolymer
US17/755,542 US12428505B2 (en) 2019-10-31 2020-10-30 Method for preparing olefin-polar monomer copolymer
BR112022008300A BR112022008300A2 (en) 2019-10-31 2020-10-30 METHOD FOR PREPARING A POLAR OLEFIN MONOMER COPOLYMER AND POLAR OLEFIN MONOMER COPOLYMER
EP20880543.2A EP4053174A4 (en) 2019-10-31 2020-10-30 METHOD FOR PRODUCING POLAR OLEFIN MONOMER COPOLYMERS
CA3159659A CA3159659A1 (en) 2019-10-31 2020-10-30 Method for preparing olefin-polar monomer copolymer
KR1020227018606A KR20220097939A (en) 2019-10-31 2020-10-30 Method for preparing olefin-polar monomer copolymer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911049604.4A CN112745428B (en) 2019-10-31 2019-10-31 A kind of preparation method of olefin-olefin alcohol copolymer

Publications (2)

Publication Number Publication Date
CN112745428A CN112745428A (en) 2021-05-04
CN112745428B true CN112745428B (en) 2022-05-24

Family

ID=75641243

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911049604.4A Active CN112745428B (en) 2019-10-31 2019-10-31 A kind of preparation method of olefin-olefin alcohol copolymer

Country Status (1)

Country Link
CN (1) CN112745428B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116022912A (en) * 2021-10-26 2023-04-28 中国石油化工股份有限公司 Sewage treatment method based on aeration biological filter containing porous polyethylene globule filler and application thereof
CN116023704B (en) * 2021-10-27 2024-07-02 中国石油化工股份有限公司 Hydrophilic modified porous polyethylene pellets, preparation method thereof and application thereof in membrane bioreactor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544919B1 (en) * 1999-10-06 2003-04-08 Sri International Multinuclear transition metal catalysts for preparation of multimodal polymer compositions
WO2004060901A1 (en) * 2002-12-17 2004-07-22 The Dow Chemical Company Multinuclear transition metal polymerization catalysts
KR100677869B1 (en) * 2004-07-01 2007-02-02 대림산업 주식회사 Multinuclear Metal Compounds, Catalyst Systems Comprising the Same, and Polymerization Methods of Olefins Using the Same
CN105481998B (en) * 2014-09-18 2018-05-11 中国石油化工股份有限公司 A kind of olefin polymerization catalysis and its methods for making and using same
CN109694438A (en) * 2017-10-24 2019-04-30 中国石油化工股份有限公司 A kind of alkene-alkene alkoxide polymer and preparation method thereof

Also Published As

Publication number Publication date
CN112745428A (en) 2021-05-04

Similar Documents

Publication Publication Date Title
CN111116808B (en) Preparation method of olefin-olefin alcohol copolymer
WO2019080876A1 (en) Olefin-olefinic alcohol copolymer, and preparation method therefor
CN111116807B (en) Preparation method of olefin-olefin alcohol copolymer
CN111116802B (en) Preparation method of olefin-unsaturated carboxylic acid copolymer
CN112745419B (en) Process for producing olefin-unsaturated carboxylic acid copolymer and olefin-unsaturated carboxylic acid copolymer
WO2021083358A1 (en) Method for preparing olefin-polar monomer copolymer
CN112745428B (en) A kind of preparation method of olefin-olefin alcohol copolymer
CN111116803A (en) A kind of preparation method of olefin-unsaturated carboxylic acid copolymer
CN111116780B (en) A kind of preparation method of olefin-olefin alcohol copolymer
CN113754812B (en) Process for producing copolymer of olefin and unsaturated carboxylic acid
CN112745425B (en) Process for preparing olefin-olefin alcohol copolymers
CN112745427B (en) Method for preparing olefin-olefin alcohol copolymer
CN112745423B (en) Preparation method of olefin-unsaturated carboxylic acid copolymer, olefin-unsaturated carboxylic acid copolymer and application thereof
CN112745429B (en) Process for preparing olefin-unsaturated carboxylic acid copolymers
CN112745430B (en) Preparation method of olefin-unsaturated carboxylic acid copolymer
CN112745426B (en) Process for preparing olefin-olefin alcohol copolymers
CN113754814B (en) Polar group-containing copolymer and preparation method and application thereof
CN112745422B (en) Method for preparing olefin-olefin alcohol copolymer
CN113754818B (en) Method for producing olefin-olefin alcohol copolymer and olefin-olefin alcohol copolymer
CN113754816B (en) Method for preparing olefin copolymer containing hydroxyl and product and application thereof
CN113754817B (en) Method for preparing olefin copolymer with polar group and product thereof
CN112745421B (en) Olefin-olefin alcohol copolymer and method for producing the same
CN112745424A (en) Method for preparing olefin-unsaturated carboxylic acid copolymer
CN113754811B (en) Hydroxyl-containing copolymer and preparation method thereof
CN113754819B (en) Method for preparing olefin copolymer with carboxyl

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant